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ABSTRACT
Islamic Bioethics: National Regulations and Guidelines of Human Stem
Cell Research in the Muslim World
by Azza H. Mahmoud

The utilization of human stem cells emerged recently in the Muslim world as one of the essential
valuable areas of medicine for their vital role in developing regenerative medicine and treating
chronic and incurable diseases. Existing studies indicate that most human stem cell researchers
rely on varying schools of thought in Islamic law or on an individual base to define legitimate
practices. From a policy perspective, the different Islamic religious decrees do not constitute a
unified legal framework to promote essential international collaborations. The existing literature
exhibits a limitation in comprehensive studies on human stem cell research (HSCR) in the newly
joined countries of the Muslim world regarding HSCR policy variation. This comparative
research provides for the first time cross-country comparisons of the top HSCR Muslim
countries pertaining to their religious sect and affiliation and HSCR national policies. A second
research contribution is in surveying the legal position of the Muslim countries on legal clinical
abortion to learn about its related-legal framework and inform policy consistency on HSCR. The
case-based study of the influence of the religious background of the top Muslim countries on the
legal position of HSCR components shows that HSCR is permissible in Islam and is independent
of the sect or affiliation as a barrier to a permissive policy. However, the case-based study of
abortion laws and the legal position from HSCR components show that the "restrictive" policies
in the Muslim countries prohibiting embryonic stem cell research are inconsistent with Islamic
abortion laws and embryo’s graduality view that rely on the same subject matter, the embryo's
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moral status. These findings emphasize that the variation in HSCR policies is not embedded in
the Islamic theological or philosophical reasoning but in other socio-cultural, economic, or
political issues. Revisions of restrictive policies and the constructive debates among Muslim
countries on the existing Islamic policy models are devised to bridge all the policy variations,
clear all uncertainties, and help reach a harmonized consensus on HSCR.
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1

Introduction

On August 7, 2006, the Guardian newspaper published that scientists acknowledged a
technological breakthrough at Tehran's Royan Institute in Iran after producing the Middle East's
first cloned sheep. On May 1, 2020, a breakthrough COVID-19 treatment with promising initial
results developed by United Arab Emirates (UAE) stem cell center was announced. The news
delivered that the Ministry of Economy has granted a patent in Abu Dhabi of the UAE for
developing an innovative and promising treatment for COVID-19 infections using stem cells.
Scientifically, these breakthroughs in developing countries represent profound progress in
emerging biosciences such as Human Stem Cell Research (HSCR). From the legal perspective,
Iran has a clearly established HSCR policy influenced by religious guidelines (Farajkhoda,
2017). On the other hand, there is no legal framework regulating human stem cell research
(HSCR) in the UAE; instead, scientists often rely on religious decrees outlining acceptable
practices, as in many other Muslim countries (Bapat, 2018; Flynn & Matthews, 2010).

A survey of HSCR-related literature shows that most stem cell research activities in the Muslim
World are conducted without any regulatory policies or public discussions. Differences across
countries are manifested in the diversity or absence of national policies and regulations of HSCR
in the Muslim World. For example, leading the way for the first time in the Middle East, Jordan
has decreed 2014 the first Statute under the Law of Public Health to regulate the use of ESCs in
therapy and research purposes (Al-Tabba' et al., 2020). In Malaysia, the Ministry of Health
commenced 2009 by regulating and promoting stem cell research using adult stem cells;
however, they prohibit the creation of human embryos by any means for research purposes
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(Ministry of Health Malaysia, 2009). In contrast, there are no identified laws or guidelines in
Egypt to regulate HSCR but rather recommendations from the Egyptian Medical Syndicate
allowing HSCR only on adult stem cells and prohibiting the use or the creation of human
embryonic stem cells (Sleem, 2012). Thus, several questions come into perspective regarding
HSCR and its regulations: How do laws and ethics of Human Stem Cell Research vary across the
Muslim World pertaining to its sources, research purpose, and applications? Can an informed
consensus be reached, and a harmonized Islamic regulatory framework be shaped among the
different religious affiliations to govern HSCR and promote its international collaborations?

With the rapid progress and developments in the stem cell field, especially in regenerative
medicine, researchers must operate under agreed-upon guidelines that safeguard ethical practices
and ensure transparency to gain and maintain public trust. The governance of the emerging
biosciences dramatically impacts the development and discoveries of science and is a key to the
country's social, economic, and political advancement. Consequently, policymakers are careful
when regulating science and considerate of changes in social values to ensure that scientific
activities and societal values are acceptably and accurately represented in the development of
policies for controversial applications of HSCR. Currently, international organizations and
bioethical committees worldwide, such as the International Society of Stem Cell Research
(ISSCR) and Hinxton Group, continue to monitor concerning issues regarding the support and
funding for HSCR. However, these international bodies are not recognized as universal divisions
in a way that can produce global binding policy outcomes (ISSCR & Hinxton Group official
websites). Since the success of the first laboratory isolation of human stem cells in 1998, this
innovative biomedical HSCR continues until the present to stimulate a myriad of moral,
religious, and legal debates. Unprecedented, distinct HSCR sensitivities ignited the ethical
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complications for this one area of scientific governance that diversely influences the political
dynamics, national regulations, and policy guidelines across countries worldwide. With the rapid
pace of advanced scientific technologies, the utilization of human stem cells has become of
global concern and the center of international focus (Saniei & Baharvand, 2018). This area of
bioscience offers the potential for a deeper understanding of early human development and the
creation of cell-based remedies that might help treat degenerative, incapacitated, and incurable
disorders, such as diabetes and spinal cord injury, and Parkinson's and Alzheimer's diseases.
Similarly, HSCR opens the door for creating a successful model for discovering drugs and
testing their toxicity, efficacy, and safety without experimentation on human subjects (Salter,
2007).

As HSCR has ensued, its advances provoked inevitable debates about the creation and
destruction of embryos in the process of human stem cell procurement. The current controversy
related to HSCR is not associated with its purpose and goals but rather with the source and
means of obtaining these stem cells. Nevertheless, HSCR increasingly proliferated globally with
no single universal policy or official rules to govern. Instead, each country developed its
regulations and procedures concerning its cultural perspectives and religious doctrine. In this
regard, the religious deliberations about HSCR posit various opinions and epistemological
inquiries about the moral status and respect for human dignity as opposed to its benefits and
therapeutic promise for alleviating human suffering and curing disorders (Al Tabaa', et al. 2014;
Fakruddin, 2012; Saniei, 2018; Shapiro, 2014). Moral status shows the inherent worth of
something from a moral standpoint rather than an economic, technical, or another standpoint.
With HSCR gaining ground in the Muslim World, it is essential to deliberate the surrounding
ethical issues and challenges and revisit the national regulations at present and their implications

3

on the advancement of research and the risks of its application. In the West, ethical and legal
disputes related to HSCR are substantial, and policies vary significantly from one country to
another, posing a more conservative and strict position. While the challenges to harmonization
are diverse and essential, so are the benefits of establishing uniformity in approaches to stem cell
research worldwide (Cambell & Nycum, 2005). Likewise, the response has been fraught with
moral and religious concerns and a lack of consensus throughout the Muslim world. With
varying schools of thought in Islamic law, one decree may be well adopted in a country but not
recognized as a legal or regulatory framework in another country (Matthew & Morali, 2020). As
a result, most human stem cell researchers rely mainly on the differing religious decrees to
individually define legitimate practices. From a policy perspective, the different religious decrees
do not constitute a unified legal framework or structure to promote international collaborations
with other countries that legislated HSCR. Despite conflicts and debates to reach a consensus on
ethical policies of HSCR in many Muslim countries, researchers are still pursuing HSCR and
leading in stem cell therapy, especially in diseases most prevalent in the region. Moreover,
Muslim countries are increasingly investing in scientific research and development to strengthen
the economy and develop knowledge-based infrastructures (Al-Tabba' et al., 2020).

Engagement in HSCR international collaborations proposes obvious scientific and clinical
benefits for most institutions, especially to newer institutions in the Muslim World aiming to
increase their prominence and advancement in the field. With the absence of appropriate
legislation or prohibition on HSCR, researchers in these countries take advantage of the lack of
specific regulations to carry on with HSCR considering that the need for its development and
potential benefits outweighs the concerns of its risks and dangers to human identity. The danger
lies fundamentally in the potential risk of misuse, exploitation, and obstacles in the necessary
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comprehensive collaborations with other countries that have recognized legislated laws
worldwide. Furthermore, religious and ethical conflicts arise from the idea that humans are on
the verge of playing God by manipulating and creating life. There is generally a legalized
scientific infrastructure in developed countries, and research institutions are part of the larger
community. These conditions transform research results into healthcare practices that benefit
society and monitor any unethical practices closely. Thus, with such legalized scientific
structure, the risk of exploitation of subjects or communities is minimized. In comparison, with
the absence of harmonized HSCR regulatory guidelines in developing countries, combined with
the probable existence of poverty, limited healthcare services, illiteracy, cultural and linguistic
differences, or limited understanding of the nature of HSCR, the risk of exploitation and
possibility of knowledge misuse significantly increase under these circumstances (Emanuel et
al., 2004).

Consequently, there has been an ongoing call for an international consensus or universal
standards on carefully regulating pioneering scientific and medical advances to secure their
ethical and safe application. Therefore, the essential identification of these arguments, an
analysis of the current national regulations, and the near-term reach to an informed consensus
become the crucial challenge for countries of the Muslim world that share a similar religious
background and cultural views. The anticipated consensus will help reach the required balance
between the need to preserve human identity, the need for a continuous improvement in the
quality of human life, and the global promotion of this innovative scientific research and its
applications (Cambell & Nycum, 2005; Warren, 2016). Existing studies indicate that most
human stem cell researchers rely on varying schools of thought in Islamic law or on an
individual base to define legitimate practices. The different religious decrees do not constitute a
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unified legal framework to promote essential international collaborations from a policy
perspective. The existing literature related to HSCR in the Muslim World primarily focuses on
debates on the perceptions of the moral status and rights of the human embryo (the fertilized egg)
in Islamic Law or the current state of stem cell-based therapies in individual countries. The stem
cell-related literature exhibits a limitation in comprehensive studies on the policy variation in
human stem cell research (HSCR) in the newly joined countries of the Muslim world. Only a few
studies on individual countries regarding the HSCR governmental and religious guidelines are
available.

This research aims to undertake cross-country comparisons in the field of HSCR in the Muslim
world to learn from and about HSCR current policies. The comparative research will present a
critical review of the existing stem cell literature to facilitate an understanding of the unique
position of each sect and affiliation towards HSCR and its ethics and to what extent these
regulations overlap among the different Islamic affiliations. The emphasis of this review is to
introduce and examine the various Islamic perceptions surrounding HSCR ethical issues. The
first contribution of this comparative research will be in conducting for the first time a crosscountry comparison of the top HSCR Muslim countries pertaining to their religious sect and
affiliation and the HSCR legal arrangements. The cross-country comparisons will highlight the
similarities and differences between national legal contexts of the Islamic views of the human
embryo as a research tool, the surrounding issues and the ethical measures ultimately influencing
HSCR regulations, and the HSCR policy levels in the Muslim world. The comparison will help
understand the influence of the religious sect and affiliation on HSCR policies and the
permissive legal stances of some countries to inform policy learning in other restrictive
countries. The second contribution of this comparative research will be a contribution to policy
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learning. A survey of the legal position of the Muslim countries on a close-related issue, legal
clinical abortion, is sought to learn about its related-legal framework and inform policy
consistency on HSCR. Since the ethical issues for clinical abortion and utilization of human stem
cells are centered on the moral status of the human embryo and the protection of life, the
relationship between these issues is considered synergistic. Accordingly, the legal position on
abortion will be critical in determining the unique positions of each sect and affiliation with
HSCR. This comparison is important in utilizing the interlinking of abortion laws and HSCR
activities to shape its guidelines. Furthermore, it gives coherent reasoning to exhibit a unified
position for a harmonized policy framework in the Muslim world regarding this much-debated
topic. Overall, the results of the comparative research will have an important implication in
determining a common ground among the different religious affiliations and devising a
harmonized HSCR regulatory framework in the Muslim world for credible and valuable
collaborations.
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2

2.1

Background

Stem Cells

Stem cells are the origin of all different 210 kinds of human body cells. They are a category of
unspecialized cells that can differentiate into specialized cell types. Stem cells are notable from
other cell types of two essential characteristics: they are unspecialized self-renewal cells through
cell division, and they differentiate into more specialized cells, like skin, muscle, and blood.
Human stem cells are present in adult tissues and organs in small numbers mainly to replace and
renew damaged cells (Zakrzewski et al., 2019). In terms of characteristics, there are three stem
cell categories: (1) totipotent are embryonic cells that can generate a complex organism, a
human, or an animal; (2) pluripotent cells are the blastocyst's inner mass and can self-renew; (3)
multipotent are the differentiated cells of the inner cell mass in the developing embryo and
develop into specific cell types and eventually make the different body organs (Human Organ
Transplant Authority, Pakistan).

Sources of Stem Cells
Stem cells exist in human adults (somatic cells) and human embryos. Adult or somatic stem cells
are undifferentiated stem cells found among differentiated cells in the whole body after
development. They are observed to have a restricted range of differentiation options: bone
marrow, hematopoietic, brain, eye, peripheral blood, liver, skin, umbilical cord blood, and skin
stem cells. Their characteristics make them promising for research and therapy, especially
regenerative medicine. This type of stem cell enables the daily healing, growth, and replacement
of human dead cells.
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On the other hand, human embryonic stem cells (hESCs) are more notable and valuable to
scientific and medical fields for their ability to differentiate into any cell type. They are found in
gametes, blastocysts, fetal tissues, and fetuses. This type of cell exhibits a self-renewal and a
remarkable long-term proliferative potential that can generate more than 220 cell types in the
adult human body. The latter characteristic, known as pluripotent, makes them a promising
candidate for therapeutic use in regenerative medicine (Liras, 2010).

Types of Embryonic Stem Cells
A- Naturally Generated Human Embryos: Human embryonic stem cells (hESCs) are
mainly developed from eggs in vitro fertilization (IVF), and their genesis is observed by
laboratory steps of precise controlled culturing and differentiation. First, stem cells are harvested
from the cell mass called blastocysts of five- to six-day preimplantation embryos - zygotes. The
outer membrane of the blastocysts is punctured, destroying the embryo; the inner cell mass with
its pluripotent stem cells is transferred to various culture conditions; and eventually differentiates
into every cell type in the organism (Zakrzewski et al., 2019). The main objectives of HSCR are
modeling genetic disorders, employing stem cell-based human therapies, and tissue or organ
transplantation. In terms of stem cell therapeutic potential, hESCs obtained from the early
developed embryos have massive therapeutic potential for their ability to transform to every cell
type in the human body. For this reason, researchers are focused on studying embryonic stem
cells (ESCs) despite the ethical concerns regarding obtaining these multipotent stem cells by
destroying the embryo (Farajkhoda, 2017).

B- Artificially Generated Human Embryos (Embryoids): To avoid the controversy of
endangering the embryo’s life in the process and the controversy surrounding it, the second

9

research advancement in genetics and developmental biology involved developing lab models of
early human embryos using pluripotent stem cells. These artificial embryos or embryoids are
synthetic entities with embryo-like features (pluripotent cells) not created from fertilization.
Meanwhile, scientists argue that current embryoid models do not have the potential to become
fully developed human beings (Matthews & Morali, 2020). The first artificial technique is the
Somatic Cell Nuclear Transfer (SCNT), developed explicitly for research purposes. They
create a viable embryo from the nucleus transfer of a body cell to an egg cell or ovum. The stem
cells are then harvested by destroying this cloned embryo for use in therapeutic cloning
(regenerative medicine) or reproductive cloning by implanting the cloned embryo into a host
mother for further development to its term (Hengstschlägerand & Rosner, 2021). Second is the
Induced Pluripotent Stem Cells (iPSCs), a recently developed technique. Another turning
point in stem cell therapy has made it possible to develop multipotent stem cells from adult skin
cells by genetic reprogramming, thus bypassing the need for human embryos (Takahashi, 2006).
The iPSCs resemble embryonic stem cells in their ability to differentiate into a myriad of cells
that constitute tissues and organs of the body. They can be developed, put back in the same
individual from whom they were derived, and escape immune surveillance. However, iPSC is a
long and inefficient process but can differentiate into three primary or germ layers. Another
technique that is widely implemented in regenerative medicine is Therapeutic Cloning which
involves taking a cell from a patient and joining it with a donor egg to create a blastocyst or preembryo. The goal is to harvest stem cells from the pre-embryo (blastocyst), which is destroyed in
the process, and transplant them back into the patient to treat diseases such as Alzheimer's,
Parkinson's, diabetes, and perhaps spinal cord injury.
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Most scientists argue that embryoids are not human embryos and cannot become fully functional
human embryos due to absent cells or tissues vital for implantation. In some countries where
basic research on human embryos is prohibited by law, working with imported iPSCs is
permitted. Permission is based on the fact that ESCs or an embryoid cannot develop into a
complete human being and do not meet all criteria of the local legal definition of an embryo.
Hengstschläger & Rosner (2021), in recent research, highlighted the effect of embryoid research
on the prevailing opinion on the legal status of work with hESCs and re-evaluation of the
regulations in all countries with similar embryo definitions.

2.2

Ethical Issues in Human Stem Cell Research

Since the beginning, HSCR has created a cultural dispute and tension because of its subject
matter, the human embryo. The source of stem cells is one of the most provocative topics
surrounding HSCR, with three fundamental and recurring issues in contention: the moral status
of human embryos, the purpose line of research, and complicity. Embryonic stem cell research
presents a moral problem because it focuses on two fundamental moral principles: utilitarianism
and deontology. The utilitarian principle instructs to prevent or alleviate suffering, and the
deontology principle instructs to respect human life's value. In this conflict situation of
embryonic stem cell research, the debate goes on which principle ought to be given precedence
since the two principles obviously cannot concurrently be respected. Should the destruction of
embryos be permitted for its remarkable potential medical benefits? Or should it be prohibited
since it violates respect for the value of the embryo as a potential human life? Both positions are
undoubtedly grounded in fundamental moral values of life - human dignity, the sanctity of life,
and autonomy (Fakruddin, 2008; Liras, 2010; Rispler-Chaim, 1989).
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The conflict situation revolves around determining the human embryo's moral status, which is
essentially linked to its legal status. In this context, HSCR regulations and practices in each
country manifest the view that the human embryo holds. Considering that the in vitro embryo has
a genetic constitution and is a living being with the potential to become a human being, the
embryo is regarded as sui generis1 i.e., with unique legal status. This opinion reveals three views:
first, the embryo (the fertilized egg) has a moral status starting from its constitution, a view that
is supported by both philosophical and religious opinions. According to the dominant opinions of
French, German, and Turkish doctrines, germ cells that are departed from the body cannot be
considered property, and harming these cells causes a violation of personal rights. As to the
conservative Christian position, human life begins at the moment of fertilization. The embryo is
an individual with a personality that should be treated and protected as a living human being.
Thus, from this viewpoint, HSCR is prohibited. The strong opposition to the destruction of
human embryos stresses the equality of all human beings. They argue that the frozen fertilized
eggs in the laboratory are new human beings with unique human DNA and will develop those
characteristics if implanted in a uterus. This position, supported by many scientists and ethicists,
entails that these fertilized eggs deserve the same respect as any other human being. Destruction
of embryos is placed in the same status as illegal abortion, murder, or a sacrifice of the feeblest
link for the interests of others (Fadel, 2008; Kanyıs, 2019; Rispler-Chaim, 1989).

Second, the embryo (the fertilized egg) has a gradual independent moral status, a view that is
overall supported by the Islamic faith. Analogous to the termination of pregnancy, it is more
likely acceptable in the early stages of embryo development. However, it becomes more difficult

1

sui generis, a Latin expression that translates to "of its own kind or class." In legal contexts, sui generis denotes an
independent legal classification that refers to creating a new national law or establishing international norms that
would afford protection to intellectual property.
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later as the moral status of the embryo increases with the pregnancy progress. Many measures
are instated to define the embryo's early development stages, including trimesters, heart beating,
sentience, movement, and viability. One of the measures crucially linked to HSCR is the first 14
days of the embryo's development, known as the early embryonic stage or the preimplantation
stage. Accordingly, graduality is defined by the stages of the 14-day rule, implantation into the
womb, ensoulment, and the moral status is expected to be consistent with laws of abortion and
assisted reproductive techniques (ART).

Third, the embryo (the fertilized egg) has no moral status and is viewed as a body part. Based on
this point of view, the in vitro embryo is neither a property nor a person; instead, it is viewed as
an organic material with a status no different from any other body part without any considered
moral status or human dignity. For a "being" to be destroyed, it should have an interest that is
defeated by destruction. This interest is manifested in beliefs, desires, expectations, aims, and
purposes. In the early stages of development, the embryo has none of these interests, and as a
result, HSCR is permitted. Moreover, regulations pay regard to the fact that the characteristics of
the embryo's cells are changing from totipotent and pluripotent to somatic and germ cells where
the embryo starts resembling a human being.

Another perspective of the moral conflict is the situations of in vitro and in vivo embryos. The
transfer of the embryo into the womb can be considered another sub-measure of the early
embryonic stage. The status of the in vivo and in vitro embryo does not depend on how it is
constituted or fertilized; therefore, there is no difference in moral status between them. However,
when it is transferred to the womb, the moral status of the in vitro and the in vivo is different,
and the in vitro embryo that is not used for treatment may be a subject of HSCR.
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In this account, a wide range of diverse opinions are in question on the ethical status of the
human embryo since harvesting them necessitates destroying it. Hence, scientists defined
preimplantation age limits to utilize human embryos in research. The five-to six-day period will
represent the first embryonic age limit. Some views argue that the 5-day-old embryo is too young
to attain personhood, and if developed in IVF clinics, it would go to medical waste (Matthew &
Morali, 2020). Likewise, the 14-day rule related to HSCR defines when a primitive streak
develops into the nervous system, before which human embryos have no pain or sentience.
Based on the reasoning of "when life begins," the debate concerning the destruction of human
embryos led to the implementation of a 14-day rule to enable HSCR to make use of the spare
IVF embryos where sentience and brain development of the embryos begins after 14 days
(Nishakanthi, 2019). Other conflicting and ethical issues arise at distinct phases of HSCR,
including the regulations for the donations of biological materials, informed and voluntary
consent of the donors, protecting the reproductive interests of women in infertility treatment, and
commercialization and trade of biological materials (Fakruddin, 2012).

2.3

HSCR Governance in the Global Perspective

In a fast-developing scientific and economic landscape, the global politics of HSCR is driven
jointly by scientific, economic, and cultural forces creating a global political dynamic that
translates into a series of government policies and controversial lobbying across the
international, regional, and national policy realms. Though, the subsequent unwary handling of
cultural sensitivities constantly produces unforeseeable political reactions - supporting, opposing,
or indifferent - that obscure the seeming potential of the novel technology. These obstacles
increase the instability of the stem cells market, the lack of interest of venture capitalists, and the
funding gap between science aptitude and the delivery of new treatments for chronic and
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incurable diseases. As a result, the international political competition landscape pushes states,
international institutions, and bioethics committees for political negotiations to reach a global
ethical language capable of enabling the political debate and validating the subsequent policy
decisions (Salter, 2007). Since much of the criticism in this respect results from religious beliefs
and ethical views, the perspectives of the diverse cultures and faith traditions must be
investigated and considered regarding the definition of a human embryo, the timing of
ensoulment and personhood, and the rights of the human embryo as a potential life. However,
political leaders still debate regulating and funding HSCR studies with no clear global or
regional consensus essential for interdisciplinary and international collaboration (Salter and
Salter, 2007). There is a stalemate between countries that support the total banning of all forms
of human cloning and those calling for legislating therapeutic cloning (regenerative medicine).
Notably, there is an international agreement across all countries, regions, and faiths banning
reproductive cloning and restricting research on its application. However, researchers in many
countries across the globe utilize the remaining embryos created through in vitro fertilization and
are no longer needed for infertility for therapeutic cloning (Flynn & Matthews, 2010).

National and international bioethics committees such as UNESCO's International Bioethics
Committee, the European Union's European Group on Ethics, Hinxton Group, and the
International Society of Stem Cell Research (ISSCR) presumed growing importance in the global
politics of HSCR. They established a model of self-regulation and other potentially controversial
research areas engaging many different actors and stakeholders. These bioethics committees
coordinate to provide global standard guidelines in an attempt to bring disputes to discuss and
resolve cultural conflicts related to HSCR; however, they are not recognized as universal
divisions in a way that can produce global binding policy outcomes. Many scientists and ethicists
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develop Hinxton and ISSCR's guidelines from Asia, Europe, North America, and Australia.
These organizations receive review and feedback from individuals and organizations, including
regulators, funding bodies, journal editors, patient advocates, researchers, and public members.
As a result, views, and conceptions differ considerably regarding aspects of the guidelines; some
may consider them too permissive; others may find parts too restrictive. Moreover, some
countries set well-defined legal policies that may supersede them (ISSCR & Hinxton Group
official websites). These national and international Bioethics committees are mainly developed
and applied in Europe as a political framework to seek answers to the cultural conflicts
surrounding HSCR. Their presence is limited and is identified globally only for the benefit of
their experiences, international collaborations, and political usefulness by other developing
countries with distinct cultural traditions, such as in the Muslim world. Overall, the main goal of
the bioethics committees with HSCR guidelines is to define core principles of scientific
objectivity and research integrity, to consistently revise and update them based on current needs
of scientific developments, and publish them to researchers, clinicians, organizations, and
institutions around the world. Among the core binding principles defined by the bioethics
committees for conducting HSCR (ISSCR, Hinxton Group, STA Law Firm, 2018):

1. The Principle of Respect considers an embryo as a human biological life that is granted
sanctity and cannot be damaged or controlled without enough reason.
2. The Principle of Informed Consent requires that donors be informed of all aspects and
procedures of the research before such a donation.
3. The Principle of Safety and Utility requires that research conducted with human
embryonic stem cells must have been tested on animals to avoid damaging patients and
donors alike.
4. The Principle of Non-commercialization prohibits the buying and selling of gametes,
embryos, and fetal tissue.
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5. The Principle of Transparency requires researchers to be transparent in their clinical
research and endorse the prospective registration of all trials in public databases,
regardless of phase.
Together, these principles constitute a universal systematic framework that stipulates core
practical considerations necessary to justify HSCR and the use of human embryos ethically.
Since national governments are the principal entities supporting or opposing HSCR through
legislation and funding globally, the political significance of HSCR can be weighed by the
number of these national and international organizations and bioethical committees that produce
or are requested to produce legitimate regulatory policies for this type of scientific research.

17

3

Literature Review

For the current state of stem cell therapies in Muslim countries, the existing literature focuses on
the advancement of many countries in hematopoietic stem cell transplantation (HSCT). Over the
past three decades, HSCT has become a vital therapeutic modality in managing a variety of
hematologic malignancies and inherited disorders in most Muslim countries. Matsumoto et al.
(2015) reviewed and assessed CB banking policies and initiatives in the Arab world, specifically
in Jordan, Saudi Arabia, Egypt, Qatar, and the United Arab Emirates. The study pointed out the
importance of addressing the impact of the lack of knowledge in the stem cell field, public
opinion, and awareness in the region to help reach informed decision-making.

In the context of bioethics, the most provocative topic surrounding HSCR is the destruction of
human embryos as a source of stem cells. The literature identifies three fundamental and
recurring issues in the debate: the moral status of human embryos, the purpose line of research,
and complicity. By reviewing the discourses on the controversial ethical implications, literature
shows that one way to resolve the legal consequences and determine the permissibility of HSCR
is to examine the moral status of the human embryo. Thus, the moral status represents a critical
consideration in concluding the ethical position of each country and the national legislative
decisions for this type of scientific research (Fadel, 2007; Fakruddin, 2012; Prentice, 2004;
Saniei & Baharvand, 2018). Fadel (2007) reviewed the prospects and ethics of stem cell research
from an Islamic perspective and theorized three positions for the human embryo's moral status,
including the Islamic graduality position based on the embryo's developmental stages. Kanyıs
(2019) compared the embryo's moral status views and HSCR regulations in two Muslim
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countries – Turkey and Iran. The study pointed to the contradictory logic in the Turkish system
legalizing the destruction of surplus embryos and prohibiting them for therapeutic purposes, thus
neither protecting human embryos nor helping patients seeking treatment. Nishakanthi (2019)
critically reviewed the inquiries of moral philosophy in the context of emerging technologies and
its implications on the unique position and ethics of Malaysian stem cell technology. Similarly,
Fakruddin (2012) discussed the HSCR ethical and political controversies and raised questions
about the complicity of researchers in the destruction of an embryo and the moral distinction
between creating embryos for research or reproductive purposes.

In another dimension, several stem cell studies highlighted the key arguments and concerns of
the human embryonic debate in Muslim countries. They emphasized the need for Muslim
jurisprudence conferences and organizations to discuss all the possibilities and uncertainties and
consider the potential benefit of HSCR on human health. Researchers reviewed the Islamic
ethical standpoint regarding using human embryos, the permissibility of human cloning to
harvest stem cells, and ways of its improvement in several countries such as the Eastern
Mediterranean Region, Iran, Turkey, Pakistan, and Bangladesh. The findings indicated the need
to formulate HSCR regulations, the ethical and legal status of the human embryo from a common
sociological perspective, the differences and similarities in regulations, and the incompatibility
between regulations on the practice (Abdur Rab & Khayat, 2006; Fakruddin 2012; Kanyıs, 2019;
Shamsi, 2008). Also, the findings revealed the differences in investments and clinical research
output between developed and developing countries and the importance of government
regulation and support in strengthening. Abdur Rab & Khayat (2006) emphasized the urgent
need for Muslim scholars to rationally examine the issue of HSCR and cloning, considering the
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scientific advantages and the ethical and legal implications, especially the importance of
reaching a consensus on this vital issue in the Muslim countries.

Regarding the HSCR legal status, several studies analyzed the conceptual bioethical basis for the
co-production of science, policy, and stem cell legal status in several Muslim countries. The
studies identify the common principles in the Muslim tradition on which the laws and guidelines
apply to identify the permitted and the prohibited techniques in modern technologies. However,
the findings show no binding view on the prohibition or the permissibility of any scientific
research, including modern biotechnology, as long as it benefits human life and well-being
(Abdur Rab & Khayat, 2006; Aksoy, 2005). Despite the field topic's cultural and religious
sensitivities, the literature recognizes a dominant favorable Islamic position for HSCR.
Generally, the literature shows no restrictions from the Islamic viewpoint regarding biomedical
sciences and technologies, unless expressly prohibited, as long as they are employed to improve
human life. However, the ethical assessment of HSCR using human embryos is still widely
diverse due to several factors such as the lack of a central religious authority like the Roman
Catholic church in Europe, the diversity of viewpoints in Islamic law, and the characteristics of
political regimes or social conditions. This diversity produces a different position in the ethical
assessment of HSCR for each country in the Muslim World and subsequently in its national
regulations and policy governance (Turkmen & Arda, 2008).

Recently, many countries in the Muslim world are fast developing their scientific infrastructure
for R&D as well as financing well-developed research and academic facilities to collaborate in
the novel scientific technology of HSCR. The present state of HSCR activity within these
countries will have a higher impact and will enhance international collaborations if their national
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governments strive for policy interoperability (Flynn & Mathews, 2010). Alahmad et al. (2020)
identified four research themes based on the ethical challenges related to the use of stem cells
and the essential need to promote the knowledge, education, and awareness of stem cell research
and treatment in Saudi Arabia. For the first of its kind in the Middle East, Al-Tabba’ et al. (2020)
reviewed the stem cells Statute in Jordan (JSCS), the comprehension and consistency of its
content, the gaps, and the recommendations for the substantive requirements, procedural
safeguards, and the requirements for research governance. In Malaysia, Nishakanthi (2019)
critically reviewed the ethics of Malaysian stem cell technology based on written literature to
understand its unique position towards stem cells and the impact and influence of contemporary
stem cells on Western ethics. Similarly, Saniei (2013) analyzed Iran's hESC policy in Iran
described as a 'more flexible approach based on the viewpoints of stem cells scientists,
embryologists, and ethics committee members on hESC research policy in the Shia Muslim
country.

The ethical disputes surrounding these emerging technologies throughout the Muslim world have
been substantial, with moral and religious concerns and a lack of consensus. Despite the ethical
issues surrounding HSCR, as discussed above, the literature indicates that the present state of
HSCR activity within several Muslim countries shows a substantial scientific contribution on the
national and international level in a few decades. Engagement in HSCR international
collaborations of these countries proposes the existence of national policies and guidelines for
most institutions to exchange information with other countries and increase their prominence and
advancement in the field, as opposed to countries with limited facilities for cell-based therapy
and advanced technologies.
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Worldwide, the governing bodies positioned themselves from HSCR regulatory policies in
different multitudes: the UN Sixth Committee focused on legal issues and agreed to delay
consideration of the banning proposal of HSCR globally. The World Health Organization
(WHO) opposed the ban on HSCR techniques. The 1997 UNESCO Universal Declaration on the
Human Genome and Human Rights state that " practices contrary to human dignities, such as
reproductive cloning of human beings, shall not be permitted”. The Council of Europe's
Convention on Human Rights and Biomedicine bans the creation of embryos entirely for
research purposes. Researchers, ethicists, and various spokespersons from 14 different countries
'Hinxton Group' issued a set of legal and ethical guidelines relating to HSCR to address
inconsistent international laws in this area. In the United States, no federal funding is available
for HSCR. Only eleven states support research to improve scientific exchange, coordination, and
collaboration. The rest of the states restrict research in this field based on ethical standards. In
Asia, there is a vast diversity of principles and religions with no consensus on HSCR, and the
region projects a fragmented legislative landscape like Europe. Even though the spiritual and
cultural codes in many Asian countries consider the economic incentives resulting from
technological advances, it emphasizes the fear of knowledge misuse and commercial
exploitations. Correspondingly, many African countries support the total banning of HSCR out
of concerns about women's exploitation as sources of human eggs and problems from cultural
norms that value a broad definition of human life (Dhar & Hsi-en Ho, 2009).

By surveying the laws and guidelines of the 22-top research-intensive countries, Matthew and
Morali (2020) examined and highlighted the existing barriers and obstacles related to the
expansion of research using human embryos and embryoids. The study emphasized the
importance of collaboration with policymakers and stakeholders to set clear laws, reach a global
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ethical language, and develop the appropriate regulations and guidelines within each national
context to promote this type of research. Similarly, Rispler-Chaim (1998) stressed the distinct
dynamic nature of ethics and argued that basic ethics in society or religion must be evaluated
regarding their period and place. For example, the study underscored how Islamic bioethics
demonstrates a progressive and consistent relationship with medical advances and legally aligns
with recent discoveries. Cambell & Nycum (2005) suggested a model for harmonizing the
regulation of HSCR by concentrating efforts on universal norms and principles rather than
specific rules. Harmonization is recommended to be commenced and established by an
independent international agency of diverse cultural identities, perspectives, and interdisciplinary
expertise.

Since HSCR is a newly pursued scientific discipline in the developing Muslim World, the
contribution of this research is in conducting for the first time an HSCR cross-country
comparison and comprehensive case-based studies of the state and the national guidelines of this
novel type of scientific research. The case-based studies will highlight each policy window's
existing barriers and restrictions concerning each country’s religious affiliation and its position
on close-related issues such as legal clinical abortion. The comparative research anticipates
identifying common policy aspects for harmonizing an HSCR regulatory framework and helping
reach a policy consensus in the Muslim world. The agreed-upon regulatory framework opens the
way to promote legal coordination and scientific collaborations nationally among Muslim
countries and internationally with countries of regulated HSCR. Muslim countries in prospect
will span the Middle East region, Asia, and Africa geographically.
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4

Theoretical Framework

The ethical disputes surrounding these emerging technologies throughout the Muslim world have
been substantial, with moral and religious concerns and a lack of consensus. Despite the ethical
issues surrounding HSCR, as discussed above, the literature indicates that the present state of
HSCR activity within several Muslim countries shows a substantial scientific contribution on the
national and international level in a few decades. Engagement in HSCR international
collaborations of these countries proposes the existence of national policies and guidelines for
most institutions to exchange information with other countries and increase their prominence and
advancement in the field, as opposed to countries with limited facilities for cell-based therapy
and advanced technologies.

4.1

HSCR Governance in the Islamic Perspective

The legislation and principles in the Islamic tradition (Shari’a) are constructed collectively from
five primary sources: the Holy Quran, the Prophetic traditions (Sunnah), Consensus (Ijmaa),
Analogy (Qiyas), and Intellect and reasoning (Ijtihad). Most Muslim-majority countries integrate
Shari’a into their legal framework, where constitutions commonly refer to Shari’a as the primary
source of law. There are two main sects within Islam: Sunni Muslims and Shi'ia Muslims.
Different schools of thought - the most prominent of which are Hanafi, Maliki, Shafi’i, Hanbali,
and Ja'afari - established methodologies and practices for interpreting and extracting rules from
the primary scriptural sources (Al-Tabba’ et al., 2020). The schools of thought show a large
amount of tolerance between schools’ legal rulings and overlap in about 75% of the legal
inferences and conclusions. Variances among schools in jurisprudence exist due to
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methodological differences in reasoning or authentication of the principal scriptural evidence.
Different jurisprudential viewpoints may exist among the orthodox and progressive scholars of
the same school or viewpoints on newly emerged issues may be revised and updated by its
contemporary scholars. Islam does not have a central authoritative structure, and no single school
or theology dominates Islamic thought. Instead, there is a diverse understanding of how to
practice Islam and a large amount of tolerance between schools' legal rulings. Various areas of
Shari’a intersect with the Western perception of law – such as equality and respect for human
sanctity - while others link more specifically to living life by the scripture (Esposito, 2014). For
example, the Islamic scripture, in accord with Human rights codes, instructs universal equality
and respect for human life as interpreted from the text:
1. "And if anyone saved a life, it would be as if he saved the life of the whole people" – the
moral message of this verse means that this life-saving mission is universal without any
space, time, and faith partitions.
2. "And make not your own hands contribute to (your) destruction" - Through an analogical
understanding, this verse can be inferred as bringing from a medical perspective a note
that anyone can neither carry (actively) nor allow (passively) oneself to destruction.
Among ways of making regulations and drawing up laws in Islamic tradition, Muslim Scholars
and intellectuals apply case-based arguments and reasoning for judgment on newly emerging
ethical issues. Theoretically, they employ several Islamic principles and methodologies in
interpreting and extracting rules that have been introduced by Islamic scholars, jurists, and legal
experts in related disciplines, including: (1) the principle of “the Public Interest"; (2) the
principle of “Necessity”; (3) the principle of “No Awkwardness"; (4) the principle of “Do No
Harm" is to be neither harming nor reciprocating harm, another harm, or a similitude should not
ward off harm; and (5) the principle of “A severe harm shall be removed by a lesser harm", i.e.,
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in the presence of two harms the commission of the lesser one shall ward off the greater one
(Farajkhoda, 2017; Nur, 2020; Rispler-Chaim, 1989). Similarly, Muslim Scholars and
intellectuals apply the concept of Intellect and reasoning (Ijtihad) and the principle of “the Public
Interest.” In the juristic sense, the principle of Intellect and reasoning (Ijtihad) is a method of
exercising personal conclusions to avert any inflexibility or injustice that may be deduced from
the literal textual implementation of the law. The concept of Ijtihad plays a prominent role in the
reworking of Islamic law to the shifting needs of societies. It authorizes retreat from an instituted
precedent in support of a different ruling for a stronger reason (Aksoy, 2005; Saniei &
Baharvand, 2018). Institution of the above-mentioned Islamic principles helps present laws for
newly emerged ethical concerns and solve clinical bioethics problems and research in question.
Based on these principles, it can be concluded that any effort to heal an ailment of any kind, for
any reason, and even on any ground, must relentlessly be pursued.

In the case of HSCR, medical knowledge and clarity are needed to decide the necessity, level of
harm, and degree of life-threatening situations based on which the ruling of a "heavier harm"
should take precedence. Meanwhile, countries that share similar socio-religious beliefs and
scientific interests approach new knowledge and technologies in diverse ways due to the direct
influence of historical, cultural, and sociological perspectives. Similarly, the institutional
framework and the mobilization of stakeholders are among the factors that may explain the
variation in rulings on the same issues (Nur & Tulungagung, 2020; Saniei, 2018). The bioethics
of HSCR is inseparable and essentially linked to Islamic jurisprudence and social principles. The
basis for the regulation of HSCR relies fundamentally on the source of the stem cell, the purpose
of research, and the symbolic moral right of the embryo. From the Islamic perspective, the
debate on HSCR builds on three main arguments: (1) At what developmental stage is the human
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embryo considered a living human being, and (2) How does HSCR conflict with Islamic beliefs?
(3) What are the collective outcomes and advances that it would add to the quality of human life?
Consequently, the religious examination of HSCR ethics and the embryo's moral status becomes
essential and maintains precedence in the Islamic Shariah from the ethical relativism perspective,
a fundamental disposition of the Muslim population (Devolder, 2005; Nur & Tulungagung,
2020).

An important aspect of consideration regarding the variation in the Islamic stance from HSCR is
the absence of a central authoritative structure and orthodox prominent legal schools
(affiliations) of diverse viewpoints regarding gestational stages of development. According to
Saniei (2013) “Fatwas on these modern debates vary among the different Islamic schools of
thought; these Islamic rulings actually reflect local customs, cultures and moral sentiments”. The
author added, “Countries with similar religious backgrounds and, perhaps, scientific interests
may therefore approach new knowledge in different ways” (p. 349). It is claimed throughout the
stem cell-related literature that the Islamic stance from the modern debates on the embryo's
moral status varies among the sects and Islamic affiliations. Fatwas and Muslim scholars' rulings
on these modern debates are not legally binding and differ among the prominent Islamic schools
of thought, reflecting local customs, cultures, and moral sentiments. Accordingly, a case-based
study of the religious background of the Muslim countries and its influence on the legal position
of HSCR moral issues and rulings for its components helps understand the variation in HSCR
national policies in the Muslim world.
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4.2

Moral Status of an Embryo in the Islamic Law

Muslim scientists and scholars undertake all biomedical technologies that may result in
beneficial therapies for currently incurable debilitating diseases. To this end, Islamic viewpoints
on HSCR revolve around the notion of human life sanctity, which is considered to begin later
when the ensoulment occurs, and the embryo becomes subject to the ethics of human dignity.
The fundamental question that all debates revolve around and generate variation in policies is:
whether we allow destroying one life (destruction of the embryo) to save another one or we
should close our eyes to the potential of life-saving therapies out of respect for the potential life
of the embryo as a human?

Islam does not place a judgment on an embryo that is not fully developed, whether within or
outside the womb. According to Shari’a or Islamic law, there is a distinction between "actual"
life and "potential" life. In this context, there is an apparent distinction between the fertilized
ovum in the dish or a test tube and the fertilized ovum in the body of a human being. In the case
of IVF embryos, they are produced in the laboratory merely for infertility treatment and
reproduction. Due to the scientific limitations of the in vitro fertilization technique, they are
produced in surplus of what is needed, which will be frozen for a certain period, 5 to 10 years in
most countries, then discarded. It has been part of the argument that if these embryos were
initially treated like fully developed human beings, it would have been prohibited to produce
them in excess and destroy them afterward. Apparently, the destruction of the IVF
supernumerary embryos is not considered in any context as abortion since no one considers
human beings. From this standpoint, proponents believe that it is morally permissive to use
surplus embryos for life-saving research purposes (Turkmen & Arda, 2008).
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Second, Shari’a views the destruction of human embryos in research as ultimately linked to the
"developmental view" of human embryos less than 14 days old. The embryo has a gradual
independent moral status, a view overall supported by most Muslim scholars. Graduality2 is
provided by the stages of the 14-day rule, implantation into the womb, and ensoulment. The
graduality status is undoubtedly witnessed in the abortion and assisted reproductive techniques
regulations in Muslim countries and most Muslim scholars (Kanyıs, 2019). Arguments build on
the fact that these embryos are rudimentary in development to be considered individual
organisms. Given the consequentiality approach, the embryo has none of the vital characteristics
of personhood, such as uniqueness, sentience, the cognitive capabilities of consciousness, and
reasoning and self-awareness - to determine the morality of actions (Agbedia & Godwin, 2013;
Devolder, 2005). Thus, it is believed that these embryos should not be granted protection at the
expense of legitimate vital scientific research for collective health benefits. However, it is agreed
that embryos have a status greater than other tissue, and their rights increase as it transforms
from one stage to another. These embryos should have particular respect that would require
legitimate reasons to use, create, discard, and experiment on them (Fadel, 2008). Accordingly,
Muslim scholars define the following gestational stages:

1. Fertilization to implantation (7-day rule),
2. From implantation to the appearance of the primitive neural streak at the end of the
second week (14-day rule),
3. Ensoulment and beginning of personhood (120-day rule), and
4. Viability, which has traditionally been set at 24 weeks.
2

In Islam, it is believed that a soul is introduced into the embryo when it is four months old. This view of most jurists
is based on the Tradition (Hadith) narrated, which means :
"Verily, the creation of each one of you is brought together in his mother's belly for forty days in the form of seed;
then he is a clot of blood for a like period, then a morsel of flesh for a like period, then there is sent to him the angel
who blows the breath of life into him and who has commanded about four matters: to write down his means of
livelihood, his life span, his actions, and whether happy or unhappy…." Related by Bukhari and Muslim.
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A third Islamic perspective on hESCs is based on the concept of ensoulment, which has been
thoroughly debated and widely documented. An embryo is only considered a human life after
four months with the existence of a soul. The debates concluded in distinct variations in Islamic
jurisprudence on when ensoulment occurs, when human life starts, and the sanctity of the
embryo prior to this phase. Most Muslim scholars agree that human life begins between 40 or
120 days after conception and unanimously agree that human life after ensoulment must not be
transgressed against (Nishakanthi, 2019). Also, most Muslim scholars agree with therapeutic
cloning using IVF supernumerary early pre-embryos. The early pre-embryos are considered
worthy of respect but not granted the complete sanctity of the embryo after implantation in the
womb and specifically after ensoulment (Farajkhoda, 2017). Thus, differences in opinion among
Islamic schools in this regard define two-time points of ensoulment (40- and 120-days) and twotime points for processing (7- and 14-day rules). These time limits are consistent as well with the
international standards of HSCR. However, Fatwas and Muslim scholars' rulings on these
modern debates are not legally binding and differ among the prominent Islamic schools of
thought, reflecting local customs, cultures, and moral sentiments. Among the most prominent
Fatwas regarding stem cells that are taken as a groundwork for HSCR national policies in the
Muslim World (Shi'ia and Sunni) are the Khamenei Stem Cell Fatwa of 2002 and the Muslim
World League (MWL) Conference of 2003.

A) Shi’ite Fatwa - Khamenei Stem Cell Fatwa 2002
Iran's Supreme Leader Ayatollah Khamenei issued a Fatwa on HSCR in 2002. In the Fatwa, he
declared that hESC research is not conflicting with Shi'ia tradition and acknowledged the work
of the HSCR scientists encouraging them to advance the technology to save lives. This Fatwa has
enabled new Fatwas, practices, and legislation that allow HSCR. Iran's regulations and practices
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reflect the view of graduality - that the human embryo has a gradual independent moral status.
Policymaking Council of MOHME completed HSCR guidelines under "Ethical Guide to Gamete
and Embryo Research in the Islamic Republic of Iran” and “Ethical Guide to Stem Cell
Research” (Kanyıs, 2019) with the following articles:

Article 1: human gametes and embryos can be used for therapeutic research only when it
aims to cure human diseases.
Article 2: strictly forbids the purchase and sale of human gametes and embryos.
Article 3: prohibits the production of human embryos for research purposes. Research on
embryos is acceptable in surplus embryos only when they are not certainly be used for IVF
in the future.
Article 4: regulates that research on human embryos is permitted until the 14th day, starting
from fertilization. In the pre-ensoulment stage, it is possible to perform HSCR with both
spare/surplus embryos and embryos created for therapeutic research.
Article 5: The production of an embryo is allowed if there is no surplus human embryo
with the necessary stem cell for such therapeutic research, and research on a human embryo
is essential. However, reproductive cloning is prohibited for research purposes.
Article 6: it is regulated that the number of embryos used for research should be as few as
possible to provide protection for embryos.
Article 7: provides protection for human embryos and specifies other restrictions for
HSCR, such as the prohibition of producing chimeras and changing the genetic content of
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the gametes or embryos for transfer to the uterus, except for the purpose of preventing a
specific illness.
Article 8: prohibits the use of a human embryo in research without donors ‘consent.
Article 9: also regulates that any research on human embryos requires the consent of
embryo owners and the permission of the Ethics Committee.
Articles 10, 11, and 12 regulate how informed consent should be taken. (p. 5)

B) Sunni Fatwa - Muslim World League (MWL) Conference 2003
The General Islamic Conference is the highest policy-making body and the source of the
League's legitimacy and capacity as the spokesperson of Muslims worldwide, expressing the
attitudes and aspirations of Muslims around the world. Within the Muslim World League, the
Islamic Fiqh Council comprises a select group of Muslim jurists and scholars who discuss severe
issues concerning the Muslim World (Muslim World League official website). Fadel (2008)
stated passages of the HSCR issued Fatwa (religious opinion) by the MWL's Islamic
Jurisprudence Council conference in December 2003, held in Mecca, Saudi Arabia which are
translated below:

It is permissible to acquire, grow and use stem cells for therapy or scientific research as
long as the cells' sources are permissible. Examples of permissible sources are adults who
consent as long as it does not inflict harm on them, children whose guardians consent for a
legal benefit without inflicting harm on the children, placenta or umbilical cord blood with
the permission of the parents, spontaneously aborted embryos or those aborted for a legally
sufficient cause and with the permission of the parents, and excess fertilized eggs produced

32

during the course of IVF and donated by the parents with the assurance that they are not to
be used to produce an illegal pregnancy. It is forbidden to obtain or use stem cells if their
source is forbidden. Examples include fetuses intentionally aborted without a legal, or
medical reason, intentional fertilization between a donated ovum and sperm, and
therapeutic cloning. (p. 80)

As stated, it is permissible under the MWL Fatwa 2003 to obtain, grow and use stem cells for
therapeutic or scientific research purposes only if they are obtained from permissible sources:

1. Adults, if consent is obtained and no harm comes to them due to collection.
2. Children, if parental consent is obtained and no harm comes to the child as a result of the
collection.
3. Placenta or umbilical cord if parental consent is obtained.
4. Embryos or fetuses that have been miscarried on their own accord or aborted for
therapeutic reasons allowed by Shari’a law, and parental consent is obtained.
5. Leftover fertilized embryos from in vitro fertilization that is donated by the parents.
However, under the 2003 fatwa, it is prohibited to procure and use stem cells from the following
sources: (1) willfully aborted fetuses and fetuses aborted without a medical reason permitted by
Shari’a law; (2) willfully fertilized donated ovum and sperm; and (3) therapeutic cloning (Fadel,
2008; Shapiro, 2014).

4.3

Position of Abortion in Islamic Law

The Quran, as the primary source of legislation, does not directly address induced abortion,
giving great discretion to the scholars’ jurisprudential perspective and the laws of individual
countries. Islamic positions on abortion are shaped by the Prophetic tradition and are
significantly different among Muslim-majority countries depending on the pregnancy conditions
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and stage of gestational development. The significant variation is related primarily to affiliations
and which grounds are legally accepted reasons for abortion (Saniei & Baharv, 2018). Within
the Muslim-majority countries, a largely conservative approach was observed where abortion is
legally permitted only in a life-threatening condition for the mother or before 120 days after
conception. Concerning other grounds and later gestational development of the fetus, abortion is
greatly disputed among the different affiliations and prohibited for fear of a "misuse" on
religious grounds rather than on theological or philosophical reasoning. Muslim scholars mostly
agree that the slightest blameworthy ground for abortion is in the life-threatening condition for
the pregnant woman and before the 120-days rule when ensoulment occurs. Muslim scholars
view the embryo's age when ensoulment occurs, whether within or outside the womb, as a living
being undergoing the growth process but not yet a human life until the existence of a soul
(Shapiro, 2014). However, regarding other grounds and later gestational development of the
fetus, it varies among the Muslim countries based on their Islamic affiliation and national Fatwas
given by renowned Muslim scholars who identified seven dimensions as legal grounds for
abortion:
▪ Abortion is permitted to save the life of the pregnant woman (L)
▪ Abortion is permitted to preserve a woman’s physical health (PH)
▪ Abortion is permitted to preserve a woman’s mental health (MH)
▪ Abortion is permitted in cases of fetal impairment (F)
▪ Abortion is permitted in cases of incest or rape (I/R)
▪ Abortion is permitted for social or economic reasons (SE)
Table 4-1 exemplifies the substantial diversity of Islamic laws across the prominent schools of
thought regarding the different gestational stages of development (Shapiro, 2014; Saniei &
Baharv, 2018; United Nations, 2014).
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Table 4-1: Legality of Abortion by Islamic Affiliations.
Embryonic Development Stages
Muslim
Sects
Sunni

Shi’ite

Affiliations
Hanafi

1
Conception to 40
days
permitted

2
40–80
days
permitted

3
80–120
days
permitted

4
120 days to
birth
prohibited

Shafi’i

majority permit
some permit

Maliki

prohibited

some
permit
some
permit
prohibited

prohibited

Hanbali

some
permit
some
permit
prohibited

Ja’afari

permitted

permitted

permitted

prohibited

prohibited
prohibited

Quranic description - Stage 1: Fertilized ovum; Stage 2: Develops into a clinging bloodlike clot; Stage 3: Clot forms into a clump of flesh; Stage 4: Ensoulment occurs.
It must be noted that the permission for abortion for all affiliations is constrained by the
recognized legal ground of the religious authority and national laws. Based on a particular
affiliation, the permission of some scholars, as in table 4-1, indicates different jurisprudential
opinions among its scholars (orthodox and progressive) or that the opinion has been reviewed
and updated later by contemporary scholars.

Such moral decision regarding the embryo's status is not limited to the realm of HSCR but also
other close-related issues involving the gestational stages of development, such as clinical
abortion, which have been already regulated in all Muslim countries, as demonstrated above.
Since this relationship is interlinking and the ethical issues for both abortion and HSCR revolve
around the moral status of the human embryo and the protection of life, the legal position on
abortion will be critical in determining the unique positions of each sect and affiliation toward
HSCR components. Since both cases assume the protection of life and the respect for human
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dignity and sanctity, it can be argued that these Islamic rulings regarding the moral status of the
embryo are consistent with those ruled upon abortion. Based on the above discussion, a casebased study is sought to examine the consistency of the signifying synergistic relationship
between clinical abortion and utilizing the IVF supernumerary embryos and embryoids for
HSCR.
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5

Research Design

This research employs descriptive cross-country comparisons for two case-based studies to
understand the variations in HSCR national policies and help determine a unified position for an
HSCR policy framework in the Muslim world.

The first case-based approach undertakes a comparative study of the top Muslim countries
grouped by sect and affiliation, selected for their significant HSCR international collaborations,
and HSCR legal arrangements. The cross-country comparison highlights the similarities and
differences between national legal contexts in the Muslim world focusing mainly on the Islamic
views of the human embryo as a research tool. Each country is considered an entire macro-social
unit, carried out analytically as a whole. The country’s HSCR scientific profile is identified as
the R&D as a percentage of GDP, the number of stem cell publications, the number of
international registries of stem cell clinical trials, and the number of cord blood banks (CB).
These identifiers help guide the selection of data, justification for countries to be included, and
approach to analysis. Contextual variation in the country’s HSCR legal arrangements is
accounted for by the country’s religious sect and affiliation and HSCR policies in place for each
type of HSCR.

The second case-based approach undertakes a comparative study of abortion legal positions in
the selected Muslim countries grouped by sect and affiliation and the national policies for each
HSCR type in place. The cross-country comparison will examine the consistency of the
signifying interlinking between clinical abortion and the country’s HSCR legal arrangements.
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5.1

Units of Analysis

The units of analysis for the case-based studies include the selected Muslim countries grouped by
sect and affiliation and the legal positions on abortion as units of comparison versus national
policies of the defined components for each HSCR type.

A- HSCR Components
The international formal bioethical HSCR discourse defined a common terminology with a
limited set of components that constitute the building blocks of HSCR. These components
represent the basis for ethical conflict and variation among national policies in the Muslim
World. HSCR regulation relies fundamentally on these components and their indicators: the
source of the stem cell, the embryo's age or developmental limit, and research line purpose
(Table 5-2). The policy levels for these measures will rely fundamentally on the symbolic moral
status of the embryo. The use of particular or combinations of these measures creates
configurations or hierarchies of choices that indicate the chosen legal paths of HSCR (Salter &
Salter, 2007; Salter, 2007).

B- Configurations and Policy Levels
Given the scientific and socio-economic factors in play in stem cell technology, a government or
an authorized religious agency may support or oppose a particular or a combination of
components to achieve an acceptable political compromise. Hence, different possible constructed
configurations of HSCR components result in prominent ethical positions for research line
purposes. The research will survey the policy levels for the resulting constructed configurations
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for analysis, as illustrated in Table5-3. In cultural terms, the bioethical levels move from
prohibition (the moral status of the human embryo and its sanctity are preserved from the time of

fertilization) to permission (the moral status of the human embryo diminishes, and the status
is attached to its scientific, economic, and social utility).
Table 5-2: HSCR Scientific and Ethical Components.
HSCR Components
Sources of Human
Stem Cells (How?)

Type of
Research
Non-Embryonic

Embryonic
Naturally
Generated
Embryonic
Artificially
Generated
(Embryoids)

Indicators

Measures

Adult Stem Cells
(Brain, Skin, Bone
Marrow, Liver, etc.)
non-IVF donated
(Umbilical cord, placenta,
skin, deciduous teeth, fetal
tissues, aborted fetuses,
etc.)
IVF supernumerary,
creation lines

Y/N

Cloning (Human, Human
parts)
Somatic Cell Nuclear
Transfer (SCNT)
Induced Pluripotent Stem
Cells (iPSCs)
5-, 14-, 40-, or 120-days
past fertilization

Y/N

Y/N

Y/N

Y/N
Y/N

Embryo Age or
Embryonic
value
Developmental limit
(When?)
Research Line
All types
Therapeutic (Th)
value
Purpose
Research (R)
(What for?)
Reproductive (Rp)
The value “- “indicates nonspecific policy or no record at present.
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In political terms, the regulatory policy follows the same continuum from "restrictive"
(protection of the early human embryo) to "permissive" or liberal (no moral status of the embryo
but simply an instrument in the application of HSCR). The political impact of these
configurations is translated into policy levels legitimated by ethics, where states adopt individual
positions and policies according to social and religious guidelines.

Table 5-3: Policy levels of HSCR Policies and Guidelines.
Policy Level
Restrictive

Restrictive
Compromise

Permissive
Compromise

Permissive
or
Liberal

Policies
Permission
Procurement of adult stem cells
(from brain, skin, bone marrow,
liver, etc.).
Procurement of non-IVF stem
cells (from the umbilical cord,
placenta, fetal tissues, aborted
fetuses, etc.)
Procurement of hESCs from IVFsupernumerary embryos.
Restricted by an age limit or a
creation date.
Creation and procurement of
hESCs, including SCNT, iPCS,
and cloning.
Restricted by an age limit and
application.

Prohibition
Research using embryos or
cell lines derived from
embryos.
Research using embryos or
cell lines derived from
embryos.
Research using embryos or
cell lines derived from
embryos beyond an age limit
or a creation date.

For example, under Australia's Research Involving Human Embryos Act 2002, IVF
supernumerary embryos (What?) are qualified as "excess "for use in research only if the creation
date is before April 5, 2002 (when?), and only for therapeutic purposes (what for?). So, the
configuration is defined by the ethical criteria "How?" "When?" and "What for?" resulting in a
"permissive compromise" policy with the creation line date limit of April 2002 and therapeutic
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line purpose only. Otherwise, IVF supernumerary is prohibited, and the "restrictive compromise
"policy level is effective (Salter & Salter, 2007). Regarding the sui generis status of the in vitro
embryo (the fertilized egg) discussed before, policy level 1 reflects the conservative view of the
human life beginning just past fertilization, policy levels 2 and 3 reflect the status of graduality,
and policy level 4 reflects no moral status for the in vitro embryo.

5.2

Methods

To understand the surrounding issues and the ethical measures of HSCR in the Muslim world,
this comparative research examines the HSCR profile of the Muslim countries, surveys the
existing bioethical policies and guidelines concerning the perceptions of the human embryo’s
moral status (the fertilized egg), and the legal position from HSCR and abortion in Islamic Law.
First, a cross-country examination of the HSCR profile is conducted. The examination includes:
(1) the country's R&D investment profile in R&D which is conventionally depicted in research
intensity (GERD as a percentage of its gross domestic product GDP). The GERD will provide an
insight into the prominence of R&D and the priority in the country's budget; (2) the existence of
bioethics committees (or equivalences), expert and public debates, and (3) the country's
collaborations with international HSCR bodies such as the number of stem cell-related research
publications, stem cell-related clinical trials, and the number of registered Cord blood (CB)
banks. These indicators are used to guide the selection of the Muslim countries for the casebased studies.

Second, the examination surveys the profile of the top contributors of Muslim countries in HSCR
regarding their Islamic affiliation, the legal position of the various HSCR constructed
configurations regarding non-embryonic stem cell research, followed by the legal position of
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each country concerning both types of embryonic stem cell research. Based on examining the
constructed configurations or paths of the HSCR components, the research investigates the
influence of the country's sect and affiliation on the policy level of the HSCR components; and
the consistency of HSCR legal positions with the country's religious position on clinical
abortion. Eventually, the case-based studies facilitate comparing and contrasting the current legal
status of HSCR and the potential pathway in the Islamic tradition to reach a harmonized
regulatory platform and a policy consensus for HSCR activities in the Muslim World.

Muslim countries reside in several sub-regions of Europe, Asia, Africa, and the Middle East.
These sub-regions comprise about 50 Muslim countries, primarily located in the Middle East
region – Appendices Table1. A wide range of international open-access statistical databases is
employed in the cross-country examination such as UN data, UNESCO, World Bank Open Data
(WB), and UNCTAD to provide data on the socio-economic profile of the Muslim countries.
HSCR data associated with the research components and policy levels for the top Muslim
countries are provided from scholarly publications and datasets of stem cell organizations. These
stem cell datasets include the International Society for Stem Research (ISSCR), Hinxton Group,
Arab Scientific Community Organization, the Muslim World League, and other datasets
presenting the most recent and reliable data on global and national HSCR regulatory policies
(Appendices Table 2).

To evaluate the state of HSCR in the top Muslim countries, the number of stem cell researchrelated citations are identified from the Web of Science - Science Citation Indexing – using
search queries with keyword strings (“TI = stem cell” AND “COUNTRY= respective country”).
Data on the number of privately and publicly funded clinical studies conducted worldwide are
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retrieved from the open-access database “ClinicalTrials.gov". The number of registered Cord
blood (CB) banks are available on the Parent's Guide to Cord Blood organization's official
website. Search queries (“Country = respective Country”) are used for each country (Appendices
Table3).
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6

Results

HSCR data linked to the country's profile and bioethics national policies are surveyed to analyze
the existing HSCR regulations and guidelines as well as abortion laws. The data includes the
profile indicators of the Muslim countries, countries’ sect and affiliations, the national policies of
the defined components for each type of HSCR, and the countries’ legal positions on abortion.
To understand the variations in the HSCR national policies and the influence of the different
sects and affiliations, cross-country comparisons of the national policies of HSCR primary areas
(non-embryonic and embryonic) and legal positions on abortion are conducted.

6.1

HSCR Profile of the Top Muslim Countries

The Muslim World views science and biomedical technology as a mechanism for improving
their well-being and the economy. Countries that prioritize R&D and invest in HSCR are
significant contributors to HSCR outputs or determinants in terms of publications, clinical trials,
and the number of Cord blood (CB) banks (Appendices tables 3 and 4). These research intensity
indicators select the top 17 countries in HSCR, as demonstrated in Table 6-4. The top 17 Muslim
countries span Asia, Africa, and the Middle East. Due to their relatively solid scientific outputs,
the top 17 Muslim countries are considered the ideal selection for examining their national
guidelines and regulations policies of HSCR practices (Appendices Table4). Among the top 17
Muslim countries, the data show that only Iran and Jordan have HSCR societies or public
debates. For HSCR regulation, the data identify that 10 out of 17 countries have HSCR national
policies and guidelines. Bioethics of HSCR in these countries is governed by government
ministries or joined to religious jurisprudence. Table 6-4 demonstrates the national agencies and
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authorities that define HSCR policies for these countries. For the top 17 countries, R&D
investments as a percentage of GDP range from 1.44 to 0.12, with Malaysia on the top
(worldwide value is about 2.81 for the USA). Related stem cell publications count from 2025 for
Turkey to 24 for Kazakhstan. Similarly, Turkey tops the number of stem cell clinical trials with
98. As shown in Table 6-4, the growing numbers indicate that all the top 17 countries witness
significant investments in new public, private, and hybrid Cord blood (CB) banks.

To examine the link between the legal position of the top 17 Muslim countries from HSCR
components, the review of laws and guidelines centered on two areas: non-embryonic and
embryonic stem cell research.

6.2

Non-Embryonic Stem Cell Research in the Top 17 Muslim Countries

In the account of non-embryonic stem cell research, the policy level of the top 17 Muslim
countries using adult and non-IVF stem cells is identified as "restrictive compromise" (policy
level 2), as demonstrated in Table 5-3. All countries of all affiliations legally permit the use of
both components of non-embryonic stem cells in research and therapy, demonstrating a
progressive stance in this area of stem cell technology (Appendices Table 5).

Data shows that the legal position for all the top 17 countries of all affiliations to the HSCR
components of non-embryonic stem cell research (adult and non-IVF stem cells ) permit the
procurement of adult stem cells derived from brain, skin, bone marrow, liver, etc.; and non-IVF
derived from the umbilical cord, placenta, fetal tissues, aborted fetuses, etc.) for therapeutic
purposes. Hematopoietic and umbilical cord transplantations are the most established form of
stem cell therapy in these countries (Gopalan & Mohamed, 2020). Embryonic Stem Cell (ESC)
Research in the Top 17 Muslim Countries.
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HSCR guidelines in Muslim countries align in general with the universal moral rules defined by
the Guidelines for stem cell Research and Clinical Translation (2016) of the International Society
for stem cell Research (ISSCR). The focus in this HSCR area - Embryonic Stem Cells (ESCs) is on the in vitro culturing or processing of naturally and artificially generated human preembryos. All the top 17 Muslim countries prohibit using cultured ESCs in research related to
human germline gene therapy or for reproductive purposes at all stages of development (Table 65).
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Table 6-4: HSCR Profile of the Top 17 Muslim Countries by Affiliation.
Country

Religious
Affiliation

HSCR
HSCR
Societies National
/ Public Policies
Debate

HSCR Authority

R&D
as % of
GDP

Publications
(TI="Stem
Cells")

Clinical
Trials
(TI="Stem
Cells")

Cord
blood
(CB)
banks

Qatar

HNB, MLK

N

Y

by Law; National Fatwa

0.82

45

0

3

Saudi
Arabia

HNB

N

Y

SFDA; 2003 MWL Fatwa

0.58

607

24

3

Bangladesh

HNF

N

N

Ministry of Health and Welfare

#N/A

27

1

1

Egypt

HNF

N

N

Egyptian Fatwa Council 2007,
Ban by MOHP 2009 of ESC
Therapy

0.72

430

63

5

Jordan

HNF

Y

Y

2003 MWL Fatwa, Statute 2014;
Law number 47 on Public Health
(Article 6)

0.71

113

25

2

Kazakhstan

HNF

N

N

by Law - Article (99); Covenant
Article 15 (1, 12, 15)

0.12

24

2

1

Pakistan

HNF

Y

Y

Pakistan Medical Research
Council (PMRC)

0.24

125

15

3

Turkey

HNF

N

Y

by Law; MoH

0.96

2025

98

6

Oman

IBD**

N

N

-

0.22

37

1

3
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Country

Religious
Affiliation

HSCR
HSCR
Societies National
/ Public Policies
Debate

HSCR Authority

R&D
as % of
GDP

Publications
(TI="Stem
Cells")

Clinical
Trials
(TI="Stem
Cells")

Cord
blood
(CB)
banks

Algeria
Morocco
Nigeria
Tunisia

MLK
MLK
MLK
MLK

N
N
N
N

N
N
N
Y

MoH
by Law

0.54
0.71
0.13
0.6

108
29
38
75

2
0
0
3

0
1
1
0

UAE

MLK

N

Y

by Law; Dubai Healthcare City
Authority - Regulatory (DHCR)

1.3

47

6

7

Indonesia

SHF

N

Y

0.23

134

31

3

Malaysia

SHF

N

Y

by Law - MoH Decree &
Regulation - Indonesian Patent
Act No. 36 2009
by Law; Guideline for Stem Cell
Research and Therapy (2009)

1.44

256

22

4

Iran

SHI

Y

Y

Khamenei Stem Cell Fatwa 2002;
Ministry of Health and Medical
Education

0.83

1206

77

1

Religious Sects and Affiliations: Religious Sects and Affiliations: S=Sunni; HNF=Hanafi; SHF=Shafi'i; MLK=Maliki;
HNB=Hanbali; SHI=Shi’ia; IBD **=Ibadi is not identified as one of the prominent Sunni affiliations; MWL= Muslim World
League; MoH= Ministry of Health.
Table 6-4: Continued
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6.3

Embryonic Stem Cell in the Top 17 Muslim Countries
A- Naturally Generated Human Embryos

As demonstrated in Table 6-5, basic research on human embryos generated from IVF
supernumerary is prohibited by 6 out of the 17 top countries: Turkey, Algeria, Morocco, Nigeria,
Tunisia, and Indonesia. Prohibition is issued by law, either by the constitution or governmental
ministries. In this context, cultural and traditional beliefs are assumed to hinder embryonic stem
cell research in these countries with no reference to a regional or national religious decree or
Fatwa. Due to limited resources and lack of field knowledge, Bangladesh and Oman have no
record of ESC research (Devolder, 2005; Ismail, 2020). In Egypt, ESC therapy was banned by
MOHP in 2009 and by a National Egyptian Fatwa Council issued in 2007. Despite the ban, ESC
research exists. Furthermore, the creation of stem cells by cloning (such as HSCT) that is not
done for reproductive purposes is generally accepted among scientists in private research centers
(Sleem, 2012). For Oman, there is no published record of ESC research. Only HSCT using adult
stem cells from bone marrow, peripheral blood, and cord blood has been carried out for three
decades (Dennison et al., 2008; Ismail, 2015). In contrast, eight countries institutionalized ESC
research allowing the use of the IVF supernumerary embryos and the establishment of new
human cell lines from discarded embryos from fetal or adult stem cell lines before two different
time points (5- and 14-day rules) for research and therapeutic purposes. Jordan and the UAE set
a 5-day rule limit, while six countries set an alternative universal limit, the 14-day rule. Based on
this data, these countries adopt a "permissive compromise" HSCR policy (policy level 3).
From the Islamic jurisprudential perspective, all countries of the Hanbali and Shi’ia affiliation
allow ESC research by law and religious decree. In contrast, countries of Maliki affiliation,
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except for the UAE, prohibit ESC research. The UAE does not have a national legal framework
or governing rules for ESC research, yet ESC research and applications exist on an individual
base (Castillo-Aleman, 2021). For the Hanafi group, three countries (Jordan, Pakistan, and
Kazakhstan) allow the use of the IVF supernumerary embryos by law and national religious
decrees (Fatwas). These Fatwas outline acceptable practices within the Islamic philosophy
context that encourages scientific research directed toward finding cures for human diseases. For
the Shafi'i affiliation, Indonesia prohibits using the IVF supernumerary under the Indonesian
Patent Act. The Ministry of Health views that only adult stem cells are suitable for conditions in
Indonesia and would be acceptable from a moral and religious perspective (Utomo, 2012). On
the other hand, the newly revised Malaysian stem cell guideline allows research on ESCs derived
from IVF supernumerary embryos. It follows the 120-day limit based on its Islamic practice that
justifies human embryonic stem cell research and stem cell technology based on the 14-day rule
adopted globally (Gopalan et al., 2020).
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Table 6-5: Legal Positions of the Top 17 Muslim Countries from Naturally Generated ESC Research by Affiliation.
Policy Level 3
IVF SuperEmbryo
numerary
Creation
Lines

Country

Religious
Affiliation

National
Policies /
Guidelines

HSCR
Line
Purpose

Authority

Qatar

HNB, MLK

Y

Y

<6 days

Th

by Law, Qatar Supreme Council of Health
(SCH), National Fatwa

Saudi
Arabia

HNB

Y

Y

<14 days

R, Th

SFDA, MWL Fatwa (2003)
IVF Act #2870/1/12

Bangladesh

HNF

N

-

-

-

Ministry of Health and Welfare

Egypt

HNF

N

-

-

R, Th

Ban of ESC Therapy by MOHP (2009)
National Egyptian Fatwa Council (2007)

Jordan

HNF

Y

Y

<5 days

R

Statute 2014, MWL Fatwa (2003)

Kazakhstan

HNF

N

Y

-

R, Th

by Law - Article (99); Covenant Article 15(1,
12, 15)

Pakistan

HNF

Y

Y

<14 days

R, Th

Pakistan Medical Research Council (PMRC)

Turkey

HNF

Y

N

Oman

IBD**

N

-

by Law, MoH
-
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-

-

Policy Level 3
IVF SuperEmbryo
numerary
Creation
Lines

Country

Religious
Affiliation

National
Policies /
Guidelines

HSCR
Line
Purpose

Authority

Algeria

MLK

N

N

N

-

MoH

Morocco

MLK

N

N

N

-

-

Nigeria

MLK

N

N

-

-

-

Tunisia

MLK

Y

N

N

-

by law

UAE

MLK

N

Y

<5 days

-

by Law; Dubai Healthcare City Authority Regulatory (DHCR)

Indonesia

SHF

Y

N

N

-

by Law - MoH Decree & Regulation - The
Indonesian Patent Act No. 36 (2009)

Malaysia

SHF

Y

Y

<14 days

R, Th

by Law – Malaysian Guideline for Stem Cell
Research and Therapy (2009)

Iran

SHI

Y

Y

<14 days

R, Th

Khamenei Stem Cell Fatwa 2002; Ministry of
Health and Medical Education

Religious Sects and Affiliations: Religious Sects and Affiliations: S=Sunni; HNF=Hanafi; SHF=Shafi'i; MLK=Maliki;
HNB=Hanbali; SHI=Shi’ia; IBD **=Ibadi is not identified as one of the prominent Sunni affiliations; MWL= Muslim World
League; MoH= Ministry of Health; R=research; Th=therapeutic; “-“indicates nonspecific policy or no record at present.
Table 6-5: Continued
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B- Artificially Generated Human Embryos (Embryoids)
Most national laws and guidelines in the top 17 Muslim countries do not explicitly state whether
this type of research is permitted or restricted but may be indirectly inferred or interpreted from
the ESC regulations in place. Embryoids require permission to create embryos, reprogramming,
and re-engineering their DNA in laboratories, especially for research and therapy (Al Tabba',
2020; Matthew & Morali, 2020). Data from the related literature show that only 5 out of 17
countries (Qatar, Saudi Arabia, Jordan, Pakistan, and Iran) allow the use of IVF supernumerary
to create embryoids or any other method employed to derive ESC lines for research and therapy
as demonstrated in Table 6-6. The ESC technology (iPSC and SCNT) is permitted, provided that
it is not implanted into a woman's uterus or used for reproductive purposes. Jordan, Pakistan, and
Iran have clear regulations on the use of ESCs formulated by the Ministry of Health, the
National Biosafety Committee in Islamabad; the Ministry of Health and Medical Education in
Iran; and the Jordanian Stem Cell Statute (JSCS), respectively. These countries present a
"permissive” HSCR policy where the embryoid is viewed as an organic material or an
instrument in HSCR with no independent moral status or sanctity. The rest of the countries
prohibit the creation of embryos explicitly for research due to traditional perspectives, fear of
misuse and exploitation, or lack of knowledge and practice rather than theological or
philosophical reasoning.

From the Islamic jurisprudential perspective, countries of the Shi'ia and Hanbali affiliations
approved the in vitro processing of ESCs (iPSCs, SCNT, and cloning) from any permissible
source of human tissue since the current embryoids models do not scientifically have the
potential to become a human being. As a Shi'i country, Iran employs the new ESC technology
based on the Khamenei Fatwa in 2003. In the Hanbali group, Saudi Arabia and Qatar follow
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Islamic decrees of MWL 2003 and a national fatwa, respectively – that allow “to acquire, grow,
and use stem cells for therapy or scientific research as long as the cells' sources are permissible”.
The Fatwa does not explicitly address the innovative technology in particular, but it can be
indirectly inferred to allow the creation of embryoids for research and therapeutic purposes. For
the Maliki affiliation, 3 out of 6 countries prohibit embryo creation from any human tissue for
any purpose. The UAE has a vague policy for the permissibility of innovative technology, and
the other two countries have no record of its practice (Castillo-Aleman, 2021). For the Hanafi
affiliation, only two countries of the group, Pakistan, and Kazakhstan, have guidelines on the
processing of ESCs. Both countries have no regulation or law that dictates the status of the
embryo, or at which point human life begins. The regulations are based on the approach of risk
management of ESC research. In Pakistan, the use and manipulation of ESCs in research or
clinical work are considered permissible if there are no reports in the literature of any adverse
effect or undesirable concern concerning the origin, potency, level of in vitro processing, or the
manner in which these are used (NGO Parallel Report on the Republic of Kazakhstan’s 2018,
Law and Justice Commission of Pakistan, 2019). For Egypt and Bangladesh, there is no clear
policy instituted to create embryoids, and only Turkey prohibits the technology by law (Arda &
Aciduman, 2009). Similarly, Oman has no mention of the innovative technology in their national
guidelines, which may be due to no hold yet on it. Lastly, for the Shafi'i affiliation, both
countries – Indonesia and Malaysia – prohibit the creation of embryoids by law (Ministry of
Health Malaysia, 2009; Utomo, 2012).

The policy level for all the top 17 countries for the HSCR components by religious affiliation is
summarized in Table 6-7. Albeit the substantial diversity, the cross-country examination of
HSCR guidelines in the top 17 Muslim countries concludes a “restrictive compromise” policy for
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four countries, a “ permissive compromise” policy for eight countries, and a “permissive” policy
for five countries. However, the #N/A value (nonspecific policy or no record) for the use of
ESCs suggests possible permissibility for five countries that can be added and change their
HSCR policy level to “permissive compromise” and “permissive” (policy levels 3 and 4) if
regulated.
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Table 6-6: Legal Positions of the Top 17 Muslim Countries from Artificially Generated ESC Research by Affiliation.
Policy Level 4
Embryo Embryo iPSCs SCNT Cloning
Creation Creation
Purpose

Country

Religious
Affiliation

Qatar

HNB, MLK

Y

Th

-

-

Th

Saudi Arabia

HNB

Y

-

Y

N

Th

Bangladesh

HNF

-

-

-

-

-

Limited resources of ESC research.

Egypt

HNF

-

-

-

-

Th

Experimental cloning is acceptable; Conflict of
regulations regarding (ESC); Lack of funds.

Jordan

HNF

Y

-

Y

Y

R

Kazakhstan

HNF

N

-

N

N

-

ESCs are imported from organizations or clinics
abroad for transplantation, diagnostic studies,
and joint scientific research.

Pakistan

HNF

Y

R, Th

Y

Y

Th

Biosafety Guidelines

Turkey

HNF

N

-

N

N

Th

IVF supernumerary embryos are discarded after
5 yrs.

Oman

IBD**

-

-

-

-

Th
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Notes

Qatar Biomedical Research Institute in 2007,
Policies in 2012

Policy Level 4
Embryo Embryo iPSCs SCNT Cloning
Creation Creation
Purpose

Country

Religious
Affiliation

Notes

Algeria

MLK

N

-

N

N

N

Morocco

MLK

N

-

N

N

N

Nigeria

MLK

-

-

-

-

-

Limited resources
Bone Marrow Registry in 2012

Tunisia

MLK

N

-

N

N

N

NO experimental work on embryos

UAE

MLK

-

-

-

-

-

SC research and applications are on an individual
base

Indonesia

SHF

N

-

N

N

-

Malaysia

SHF

N

-

-

N

-

Embryo creation is only experimental.

Iran

SHI

Y

Th

Y

Y

Th

Producing human embryos only for research
purposes is illegal.

Religious Sects and Affiliations: Religious Sects and Affiliations: S=Sunni; HNF=Hanafi; SHF=Shafi'i; MLK=Maliki;
HNB=Hanbali; SHI=Shi’ia; IBD **=Ibadi is not identified as one of the prominent Sunni affiliations; MWL= Muslim World
League; R=research; Th=therapeutic; “-“indicates nonspecific policy or no record at present.
Table 6-6: Continued
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Table 6-7: HSCR Policy Levels for the Top 17 Muslim Countries by Affiliation.

Country
Qatar

Religious
Affiliation
HNB, MLK

Policy Level Policy Level 2 Policy Level 3 Policy Level
1
4
“Restrictive” “Restrictive
“Permissive “Permissive”
Compromise” Compromise”
X
X
X
X

Saudi
Arabia
Bangladesh

HNB

X

X

X

X

HNF

X

X

#N/A

#N/A

Egypt

HNF

X

X

#N/A

#N/A

Jordan

HNF

X

X

X

X

Kazakhstan

HNF

X

X

X

Pakistan

HNF

X

X

X

X

Turkey

HNF

X

X

Oman

IBD**

X

X

#N/A

#N/A

Algeria

MLK

X

X

Morocco

MLK

X

X

Nigeria

MLK

X

X

Tunisia

MLK

X

X

UAE

MLK

X

X

X

Indonesia

SHF

X

X

#N/A

Malaysia

SHF

X

X

X

Iran

SHI

X

X

X

X

6

17

17

8+4

5+5

#N/A

#N/A

Total
17

#N/A indicates possible permissibility for nonspecific policy or no record at present;
religious Affiliations: HNF=Hanafi; SHF=Shafi'i; MLK=Maliki; HNB=Hanbali;
SHI=Shi’ia; IBD **=Ibadi is not identified as one of the prominent Sunni affiliations;
MWL= Muslim World League, R=research; Th=therapeutic
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6.4

Abortion Laws in the Top 17 Muslim countries

Diversity in the Islamic positions on abortion is related primarily to which grounds are legally
accepted reasons for abortion in terms of the pregnancy conditions and stage of gestational
development. Data of the top 17 Muslim countries by legal grounds for abortion are retrieved
from the open-access database of the United Nations (Department of Economic and Social
Affairs, Population Division, 2019). Basically, abortion is forbidden across the Muslim world
unless it is medically believed that the embryo's existence threatens the mother's life. In
comparison, the destruction of an embryo for stem cell research and therapy stands on the same
ground as abortion. Based on the Islamic legislation principles of "Do No Harm," "A severe
harm shall be removed by a lesser harm," and "Public interest," at the bare minimum, it can be
concluded that any effort to heal the disease of any kind, for any purpose, or in any field, must
relentlessly be pursued.

Table 6-8 demonstrates the legal position on abortion and the legal grounds for the top 17
countries grouped by religious affiliation. The cross-country examination of the abortion position
illustrates that clinical abortion is permitted for all affiliations on the ground of saving the life of
the pregnant woman (L). When comparing countries of the same affiliation on other grounds,
variation in legislation is significant, only three out of the 17 countries allow abortion for women
on all grounds. On the other hand, the embryo age or developmental limit varies across countries
between the 40-day rule (when the primitive streak develops into the nervous system and
sentience begins) and the 120-day rule (when ensoulment occurs, and the embryo develops a
complete moral status and rights of human life). However, within the Maliki school, which
prohibits abortion from the day of conception (Table 4-1), UAE and Tunisia presented distinct
positions for the embryo developmental limit.
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Table 6-8: Legal Positions from Abortion for the Top 17 Countries by Affiliation.
Religious
Affiliation

Legal
Clinical
Abortion

Abortion
Legal
Grounds

Embryo Age
Developmental
Limit

IVF
Supernumerary

Qatar
Saudi
Arabia

HNB, MLK

Y

L, PH, MH, F

120 days

Y

HNB

Y

L, F, MH, PH

120 days

Y

Bangladesh

HNF

Y

L

10 weeks

-

Egypt

HNF

Y

L, F, MH, PH

-

-

Jordan

HNF

Y

L, MP, MH

-

Y

Kazakhstan

HNF

Y

ALL

12 weeks

Y

Pakistan

HNF

Y

L, PH, MH

120 days

Y

Turkey

HNF

Y

ALL

10 weeks

N

Oman**

IBD

Y

L, MH, MP, F

120 days

-

Algeria

MLK

Y

L, MH, PH, R

-

N

Morocco

MLK

Y

L, MH, MP

-

N

Nigeria

MLK

Y

L

-

N

Tunisia

MLK

Y

ALL

12 weeks

N

UAE

MLK

Y

L

120 days

Y

Indonesia

SHF

Y

L, F, R

6 weeks

N

Malaysia

SHF

Y

L, PH, MH

120 days

Y

Country

Iran
SHI
Y
L, PH, MH, F
120 days
Y
Abortion is permitted: L- to save the life of the pregnant woman; PH- to preserve a
woman’s physical health; MH- to preserve a woman’s mental health; F- in cases of fetal
impairment; I/R- in cases of incest or rape; SE– for social or economic reasons; REQupon request; "-" indicates nonspecific policy or no record at present.
(40-day rule: primitive streak develops into the nervous system; 120-day rule: ensoulment
occurs)
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7

Discussion

It is fundamental in the Muslim world that the ethics of stem cell technology represent the basis
of its regulation and policymaking, which essentially link to the Islamic jurisprudence and social
principles. The cross-country comparison of the HSCR legislation and guidelines is limited to the
top 17 Muslim countries based on their R&D investments and scientific outputs in this area. The
comparison highlights the similarities and differences between national contexts focusing mainly
on the Islamic views of the human embryo and embryoids as research tools. Overall, the crosscountry comparison of the top 17 Muslim countries shows that the strict regulations of stem cell
technology are based only on some countries' traditions and social perspectives. In contrast, the
permissive or liberal approach to new knowledge and technologies relies on religious grounds
and jurisprudential decrees, particularly the Khamenei Fatwa 2002 and MWL Fatwa 2003.

HSCR Country Profile
Regarding the HSCR profile, Table 7-9 demonstrates the scientific determinants of the top 17
Muslim countries related to human stem cells and the status of their research policies. Among the
top 17 Muslim countries, it is noted that most HSCR activities in the Muslim World are
conducted in the absence of any public discussions. Decisions concerning applying this
knowledge are ultimately influenced by and debated among religious scholars, medical
physicians, and advanced research enterprises. A fundamental element in the HSCR profile is the
Cord blood (CB) banks which play a key role in stem cell transplants, including handling and
storing CB units. The therapeutic potential of these banks raised the same ethical and regulatory
concerns for the emerging stem cell technology in the Muslim world. The growing numbers of
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CB can be explained due to low fertility rates and growth rates of degenerative diseases and
genetic disorders in these countries. The international Biobanks and Biopreservation standards
define the criteria for biospecimen procurement, processing, preservation and banking,
distribution, and use for the banking centers in these countries (Al-Tabba' et al., 2020).

Table 7-9: HSCR Scientific Output of the Top 17 Muslim Countries by Number of Stem
Cell Publications.
Country

HSCR
Policies

# Publications
in HSCR

# Clinical
Trials in
HSCR

R&D as
% GDP

98

# Cord
Blood
(CB)
Banks
6

Turkey

Y

2025

Iran

Y

1206

77

1

0.83

Saudi Arabia

Y

607

24

3

0.58

Egypt

N

430

63

5

0.72

Malaysia

Y

256

22

4

1.44

Indonesia

Y

134

31

3

0.23

Pakistan

Y

125

15

3

0.24

Jordan

Y

113

25

2

0.71

Algeria

N

108

2

0

0.54

Tunisia

Y

75

3

0

0.60

UAE

N

47

6

7

1.30

Qatar

N

45

0

3

0.82

Nigeria

N

38

0

1

0.13

Oman

N

37

1

3

0.22

Morocco

N

29

0

1

0.71

Bangladesh

N

27

1

1

#N/A

Kazakhstan

N

24

2

1

0.12

62

0.96

The results show that among the top 17 Muslim countries, seven countries with relatively
scientific solid output in stem cell publications, clinical trials, and the number of CB banks do
not have any national legal framework or guidelines governing ESC research. The UAE, Qatar,
and Egypt are among these countries that invest a relatively high percentage of their GDP in
R&D (1.3, 0.82, and 0.72, respectively), developed internationally registered CB, and are among
the top contributors to publications and clinical trials. In contrast, countries such as Iran, Saudi
Arabia, Pakistan, and Jordan, with relatively substantial contributions in the field, have clear
supportive HSCR policies. The absence of national HSCR policies in these countries raises many
concerning questions regarding their unregulated HSCR practices and international
collaborations, thus opening possible malpractices or unethical conduct. Similarly, the presence
of legal gaps or delayed legal regulations of the recent developments in HSCR practices leaves
open the possibility of violation of rights and values for human health. Furthermore, the absence
of clear regulatory guidelines in these countries embeds a negative picture in which human
health is left in the hands of market dynamics. Inevitably, this situation will create a negative
attitude and a point of insecurity toward medical society and medical practices nationally and
internationally. Resolving ethical, legal, and jurisprudence concerns and challenges will help
stem cell researchers and scientists in these countries produce and publish valuable and credible
findings and introduce new products and drugs for severe diseases. Based on these results, only
52% of the Muslim countries with the largest R&D investments and HSCR collaborations have
long-established research policies and regulatory guidelines, while the rest of the countries
collaborate with no policies individually-base. In this context, this research recommends
introducing and enforcing detailed legal regulations to offer health services appropriate for
human dignity, blocking any commercialization attempts, and ensuring the dominance of science
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and ethics in HSCR practices. In addition, a comprehensive revision of the current stem cell
guidelines in similar countries of the same affiliation and cultural backgrounds, such as Iran,
Jordan, Pakistan, and Saudi Arabia, as well as any adequate international provisions that can help
regulate the explicit practices of the HSCR sectors and reinforce accountability.

Policy Levels of Non-Embryonic Stem Research
Results of the cross-country comparison indicate that non-embryonic stem cell research and
therapy (adult and non-IVF stem cells) are not entangled in serious ethical controversies across
all affiliations. Nevertheless, this stem cell area requires serious watchfulness in the countries
without national policies and limited resources, such as the case of Egypt and Nigeria. Analysis
of the existing literature shows that over the past three decades, HSCT is becoming a tangible
reality and a vital therapeutic modality in the management of a variety of hematologic
malignancies and hereditary disorders in the countries of the Muslim world (Ismail, 2015;
Matsumoto et al., 2015; Selim, 2015).

Policy Levels of Embryonic Stem Cell Research
The HSCR-related literature claims that one of the fundamental reasons behind the lack of
consensus in the Muslim world is the absence of central authority and the existence of different
schools of thought in the Islamic faith. Comparing the legal position in the top 17 countries from
non-embryonic and embryonic stem cells, the results of both Shi'ia and Sunni sects point to how
the government legislation regarding what is permitted or prohibited is independent of the
influence of the country's religious affiliation. Data clearly indicates that a different religious
affiliation is not a barrier and individual countries adopt different policies based primarily on
what is suitable to their socio-cultural, political, and economic backgrounds. For embryoids case,
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which are explicitly created to be used in scientific research they seem to be the most
problematic source of stem cells with no or nonspecific policies. Some scientists argue that the
use of spare embryos is less controversial than those explicitly created for research purposes.
This type of stem cell research is a recently developed technique that is not regularly practiced in
developing countries, especially those with limited resources and technology. On the other hand,
the prohibition of using IVF supernumerary embryos and creating embryoids for research and
therapy is issued without mentioning an Islamic jurisprudence or decree reference (tables 5 and
6). In other words, the law prohibits what the progressive Islamic jurisprudence deems
permissible under regulatory and supervisory conditions in these countries. The indicated
justification for the prohibition is the concern and risk of knowledge misuse and commercial
exploitations of the less privileged in the society, including women, children, the disabled, and
prisoners, on religious grounds. It may also be explained that the prohibition is out of the
country's desire to be a champion of ethics by avoiding the worldwide controversial topic and the
possible unethical conducted work associated with it.

In contrast, countries that allow ESC research and therapy have different affiliations, yet they
rely on a common Islamic jurisprudence in their legislation, particularly the Khamenei Fatwa
2002 and MWL Fatwa 2003. These countries present varying levels of flexibility as to when life
begins (40- or 120-days); however, they restrict the use and culturing of the embryoids to two
different time limits (7- and 14-day) for serious ESC research and the benefit of humankind.
Overall, their national stem cell guidelines strictly adhere to the general principles of Islamic
teaching about human dignity, human rights, equality, and justice and are consistent with the
revised international guidelines of ISSCR. These findings do not support the claim that the
variation in the HSCR guidelines in the top 17 countries is due to different religious schools of
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thought (affiliations) or religious perspectives. It is very well suggested that the prohibiting
countries cooperate and align with the HSCR guidelines of the pioneering countries of both
Muslim sects. The newly revised HSCR policies in Iran, Pakistan, Saudi Arabia, Malaysia, and
the stem cell Statute of Jordan are well suited as directives and models for other Muslim
countries strictly regulating HSCR or have nonspecific policies. The HSCR policies in these
pioneering countries are based on Islamic religious grounds decreed by a collection of influential
Muslim scholars of both sects. Their jurisprudential reasoning considers, above all, the respect,
dignity, and sanctity of human life well as universal moral rules. In addition, their Islamic ruling
on ESC research is not contradictory with their Islamic policies and legal positions on abortion
for all affiliations. As discussed above, the graduality view of the embryo in Islamic faith and
principles applies in both cases. This case-based reasoning would free up the spare frozen
embryos for research and from being discarded. Reasonably, we can argue that if ESC research
aims to alleviate human suffering, permitting such research would not be controversial; then,
leaving the surplus frozen embryos to die without utilizing them to save human lives can be
viewed in itself as immoral.

With this reasoning in place, the discussion mentioned above concludes that ESC research is
permissible in Islam and is independent of the sect or affiliation as a barrier to legislation and
source of variation. The permissibility is constrained by the permissible sources, research
purpose and applications, and the necessary supervisory precautions to respect human life.
Attempts to do so can bridge all the policy disagreements and variations among Muslim
countries and encourage consensus on a “permissive” policy that will promote HSCR to reach
international standards and generate more valuable collaborations.
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Policy Levels of Embryonic Stem Research and Legal Clinical Abortion
Muslim scholars and intellectuals apply case-based arguments and reasoning for judgment on
newly emerging ethical issues based on the Islamic principles discussed. The case-based
argument, in this case, links the moral status of the embryo in both clinical abortion and the fate
of the IVF supernumerary pre-embryos. All affiliations unanimously allow abortion or, in other
words, the destruction of a human embryo, and that it should not be protected at the cost of a
legitimate and fundamental reason which is the woman's life and wellbeing. Based on the
developmental view in the Islamic faith, the moral status of the early-stage embryo is
acknowledged. However, it does not rise to the level of the moral status of fully human life and
can be sacrificed to save the woman's life. One of the definitive justifications for all affiliations
to this legislation is the principle of "A severe harm shall be removed by a lesser harm." The
same reasoning would apply to the central question of the spare IVF pre-embryos; whether we
allow discarding or destroying a potential life (to extract the stem cells) as the lesser harm to
save other full human lives suffering debilitating diseases from the severe harm.

The cross-country comparison of embryonic stem cell areas (the naturally and artificially
generated embryos) reflects substantial diversity between and within affiliation groups. Analysis
of this HSCR area - Embryonic Stem Cells (ESCs) – is linked to three key issues: the fate of the
IVF supernumerary pre-embryos, the in vitro culturing, or processing time limit of these preembryos, and the artificial creation of human pre-embryos (embryoids) for scientific research.
The cross-country comparison shows that the use of human pre-embryos generated from IVF
supernumerary is prohibited independently of the affiliation group. For instance, 6 out of the top
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17 countries (35%) - Turkey, Algeria, Morocco, Nigeria, Tunisia, and Indonesia - explicitly
prohibit ESC research by law (Table 6-5). These countries belong to different affiliation groups,
and prohibition is issued by law (constitution or governmental ministries) without reliance on a
particular religious decree (Fatwa) or affiliation setting. Furthermore, reviewing the position of
these countries on clinical abortion (Table 6-7), a contradiction to the Islamic graduality view of
the embryo's moral status clearly exists. This issue is very evident in the case of Turkey (HNF)
and Tunisia (MLK). Both countries legally allow abortion on all grounds, and both prohibit ESC
research and the use of IVF supernumerary pre-embryos by law. Apparently, the view of a
gradual independent moral status is seen in the regulations on abortion and other assisted
reproductive techniques; however, it is seen as inconsistent with their regulations concerning the
use of IVF supernumerary pre-embryos. Despite the prohibition, there are no illegal charges in
both countries that count spare pre-embryos lately discarded by law as humans or abortion or
even equivalent to infanticide.
Conversely, 8 out of 17 countries (47%) – Qatar, Saudi Arabia, Jordan, Kazakhstan, Pakistan,
UAE, Malaysia, and Iran - allow the use of the IVF supernumerary embryos and the
establishment of new human cell lines from the discarded embryos before two different time
points (5- and 14-days limit) for research and therapeutic purposes based on religious decrees
(Fatwa) and joint debates between scientists and Muslim scholars. In these eight countries, the
permissibility of using the spare pre-embryos is primarily based on the two Fatwas (Khamenei
Fatwa 2002 & MWL Fatwa 2003), considering the Islamic graduality view and the reasoning
principles. Both Fatwas pay regard to the fact that the pe-embryo having the "potential" to
become a developed human life does not make it an "actual" human life by default with full
rights and sanctity. In addition, they pay regard to the scientific fact that human pre-embryos,
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which are less than 14 days old, feel no pain or sentience since no primitive neural streak appears
and develops before this time point. Hence, HSCR regulations in these countries are founded on
the above principles and account for the potential beneficial outcomes of ESC life-saving
therapies.
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Conclusion

Ethical issues concerning stem cell research are debated among medical physicians and religious
scholars worldwide. Recent studies indicate that HSCR policies are influenced by the religious,
cultural, and social positions concerning the moral status of the human embryo and when human
life is begun. In this regard, by analyzing the legal positions of the top 17 Muslim countries in
HSCR, we can argue that the fundamental basis for the variation in HSCR policies in the Muslim
world is not embedded in the different Islamic perspectives or affiliations but in other sociocultural, economic, or political issues especially the lack of stem cell knowledge, fear of
knowledge misuse, and commercial exploitations of less privileged subjects and communities.
Hence, there is a crucial need to enforce education and basic understanding among the public of
HSCR functions and therapeutic potentials to bridge the differences in HSCR legal positions and
resolve its ethical issues and uncertainties.

The literature review emphasized the paramount importance of saving lives in Islam. Islamic
jurisprudence regarding HSCR ethical issues demonstrates a prevalent pragmatism and aims to
seek a balance between Islamic culture and the innovations of modern medicine without
violation of the fundamental Islamic doctrine. Judgments of Islamic jurisprudence on the
embryo's moral status are based on the graduality view, where the early pre-embryos are
regarded as worthy of respect but do not have the complete sanctity offered to the embryo after
implantation in the uterus or after ensoulment. The cross-country comparison indicates that the
HSCR “permissive” policy adopted by 52% of the selected countries is concluded by
implementing the Islamic graduality view of the human embryo, the jurisprudential principles of
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reasoning, and the case-based approach implemented to abortion. According to the two religious
decrees or Fatwas (Khamenei stem cell Fatwa 2002 & Sunni MWL Fatwa 2003), influential
Muslim scholars representing Muslim attitudes and aspirations agreed that acquiring, growing,
and using stem is permissible cells for therapy or scientific research. Based on these Islamic
decrees, permissive policies in Muslim countries outline national guidelines on HSCR but they
are not legally binding. This permissibility is constrained by the use of legal stem cell sources,
research purpose and applications, and the necessary supervisory precautions to respect human
life. Permissible sources are mainly linked to legal marriage, legal clinical abortion, informed
consent of parents, confidentiality, no commercialization, and other management criteria.
Based on the countries’ HSCR profile, the cross-country comparison of the top 17 Muslim
countries indicates that about 41% of the selected countries with relatively scientific solid output
in stem cell publications, clinical trials, number of CB banks, and fundings work on an individual
basis without any national legal framework or guidelines governing ESC research. This finding
is alarming for the credibility and accountability of ESC practices and ethics in these countries.

Regarding HSCR policies for the different components, all Muslim countries allow nonembryonic stem cell research, where the use of adult and non-IVF stem cells are the least
problematic sources and are regulated with clear supportive policies. In contrast, the crosscountry comparison projects substantial variation for both types of ESC research (natural and
artificial generated embryos) among the top selected countries independent of their sect or
affiliation. Almost half of the top 17 countries institutionalized ESC research with "permissive
compromise" policies allowing the use of the IV supernumerary embryos for research and
therapeutic purposes. In the case of embryoids, only one-third of the top 17 countries adopted a
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"permissive" policy allowing to create embryos and simulate embryonic models. Other countries
adopted a ”restrictive” prohibiting ESC research, which is inconsistent with their policies and
legal positions on abortion that rely on the same embryo's moral status.

Based on these findings, it is evident that ESC research is permissible in Islam and is
independent of the sect or affiliation as a barrier to a permissive stance as long as it utilizes the
permissible sources, research purpose, and applications, and the necessary supervisory
precautions to respect human life. Revisions of restrictive policies and the constructive debates
among Muslim countries on the existing policy models can bridge all the policy variations and
help reach a consensus on a unified permissive legal framework that will promote HSCR to
reach international standards, clear all uncertainties, and generate more valuable collaborations.

Recommendations
In order to succeed in promoting and regulating HSCR in the Muslim world, it is imperative that
authorities drafting guidelines for ESC research must be a task force of scientists, religious
scholars, stakeholders, and professionals with an adequate understanding of scientific, ethical,
legal, and social aspects of these significant advances in biomedical technologies. The findings
of this research analysis recommend the revision of the current HSCR policies for all the Muslim
countries prohibiting ESC research and the consideration of the "therapeutic promise" offered by
the ESC innovative technologies. Based on the results, countries of common sect and affiliation
can unify their policies to be consistent with the already set rules for abortion and related issued
Fatwas. The research advises the HSCR permissive national policies in effect in the top countries
as a suitable regulatory framework that can help resolve all uncertainties and reach a consensus
in the Muslim world. Attempts to achieve these goals will lessen the feeling of national and
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international insecurity toward the stem cell scientific community in the Muslim world and
contribute to establishing healthcare policies that respect human rights and sanctity.

Second, there is a need to enforce public discussions and education to understand what stem cells
are and how they function. In developing countries where traditional and socio-cultural norms
dominate, it becomes essential and crucial to work on the awareness and education of the public
to correct the deficit in knowledge related to this issue. Furthermore, domestic stem cell therapy
and regenerative medicine are low-cost solutions for the growing number of patients with
chronic diseases, including diabetes, heart diseases, hepatitis, and blood diseases such as
thalassemia, which are relatively prevalent in these countries (Saniei, 2013). The combination of
high demand, surging science, clear supportive policies, and standard ethical norms will all
contribute to advancing biomedical technologies and particularly HSCR in the Muslim world.
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Appendices
Table 1 - Countries of Muslim Majority

Country

Total
Population

Muslim %
Of Total
Population

Country

Total
Population

Muslim %
of Total
Population

Afghanistan

37,135,000

99.7

Iran

83,000,000

99.4

Albania

3,057,220

58.8

Iraq

40,194,216

95.7

Algeria

41,657,488

99.7

Jordan

10,458,413

97.2

Azerbaijan

10,046,516

96.9

Kazakhstan

18,744,548

70.2

Bahrain

1,442,659

73.7

Kosovo

1,907,592

95.6

Bangladesh

170,000,000

90.4

Kuwait

2,916,467

74.6

Bosnia and
Herzegovina

3,849,891

50.7

Kyrgyzstan

6,500,000

80-90

Brunei

450,565

80.9

Lebanon

6,100,075

57.7

Burkina
Faso

21,382,659

63.2

Libya

6,754,507

97

Chad

15,833,116

58

Malaysia

32,730,000

61.3

Djibouti

884,017

97

Maldives

374,775

100

Egypt

95,000,000

90–94.7

Mali

18,429,893

95

The Gambia

2,092,731

95.7

Mauritania

3,845,430

99.9

Guinea

11,855,411

89.1

Mayotte

256,518

97

Indonesia

266,500,000

86.7

Morocco

38,314,130

99

Palestine

4,780,978

97.5

Tajikistan

9,540,000

97.9

Qatar

2,450,285

77.5

Tunisia

11,446,300

99.8

82

Country

Total
Population

Muslim %
Of Total
Population

Country

Total
Population

Muslim %
of Total
Population

Saudi
Arabia

34,220,000

98.2

Turkey

83,155,000

89.5

Senegal

15,726,037

96.1

Turkmenistan

6,031,187

93.7

Sierra
Leone

7,719,729

78.6

United Arab
Emirates

9,541,615

76

Somalia

11,000,000

99.8

Uzbekistan

34,036,800

88.7

Sudan

40,825,770

97

Western Sahara

603,253

99.4

Syria

18,000,000

87

Yemen

28,036,829

99.2

Tajikistan

9,540,000

97.9
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Table 2 – HSCR Profile of Muslim Countries

#Publications
Oldest
(TI="Stem
year of
Cells")
Publication

#Clinical
Trials
(Stem
Cell)

# Cord
blood
(CB)
banks

Country

Year

R&D
as %
GDP

Malaysia

2016

1.44

256

2002

22

4

UAE

2018

1.30

47

2002

6

7

Turkey

2017

0.96

2025

1976

98

6

Iran

2017

0.83

1206

2004

77

1

Qatar

2018

0.82

45

2013

0

3

Egypt

2018

0.72

430

1998

63

5

Jordan

2016

0.71

113

2004

25

2

Morocco

2010

0.71

29

2008

0

1

Burkina Faso

2017

0.70

0

-

0

0

Tunisia

2018

0.60

75

2004

3

0

Saudi Arabia

2013

0.58

607

1995

24

3

Algeria

2017

0.54

108

2002

2

0

Palestine

2013

0.51

0

-

0

1

Somalia

-

0.49

0

-

0

0

Sudan

2005

0.30

2

2016

0

0

Chad

2016

0.30

0

-

0

0

Mali

2017

0.29

0

-

0

0

Brunei

2018

0.28

2

2013

0

1

Pakistan

2017

0.24

125

2005

15

3

Indonesia

2018

0.23

134

2007

31

3

Oman

2018

0.22

37

2008

1

3

Bosnia and
Herzegovina

2018

0.20

3

2016

0

3
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#Publications
Oldest
(TI="Stem
year of
Cells")
Publication

#Clinical
Trials
(Stem
Cell)

# Cord
blood
(CB)
banks

Country

Year

R&D
as %
GDP

Azerbaijan

2017

0.18

16

2015

0

0

Albania

2008

0.15

2

2016

0

2

Nigeria

2007

0.13

38

2006

0

1

Uzbekistan

2018

0.13

0

-

0

0

Kazakhstan

2018

0.12

24

2013

2

1

Kyrgyzstan

2017

0.11

1

2014

0

0

Bahrain

2014

0.10

7

2011

0

6

Tajikistan

2018

0.10

0

-

0

0

The Gambia

2018

0.07

0

-

0

0

Kuwait

2018

0.06

19

2007

0

5

Iraq

2018

0.04

27

2007

0

0

Lebanon

-

#N/A

203

1998

11

7

Bangladesh

-

#N/A

27

2010

1

1

Syria

-

#N/A

14

2009

0

0

Afghanistan

-

#N/A

1

2019

0

0

Libya

-

#N/A

1

2022

0

0

Niger

-

#N/A

1

2016

0

0

Turkmenistan

-

#N/A

1

2018

0

0

Yemen

-

#N/A

1

2019

0

0

Djibouti

-

#N/A

0

-

0

0

Guinea

-

#N/A

0

-

0

0

Kosovo

-

#N/A

0

-

0

0

Maldives

-

#N/A

0

-

0

0

Mauritania

-

#N/A

0

-

0

0

85

#Publications
Oldest
(TI="Stem
year of
Cells")
Publication

#Clinical
Trials
(Stem
Cell)

# Cord
blood
(CB)
banks

Country

Year

R&D
as %
GDP

Mayotte

-

#N/A

0

-

0

0

Senegal

2015

#N/A

0

-

0

0

Sierra Leone

-

#N/A

0

-

0

0

Western
Sahara

-

#N/A

0

-

0

0
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Table 3 – List of Top Muslim Countries by HSCR Scientific outputs
Country
(Filter: Largest
R&D as % GDP)

Country
(Filter: Largest
#Clinical Trials)

Malaysia

Country
(Filter: Largest
#Publications in
Stem cells)
Turkey

Turkey

Country
(Filter: Largest
#Cord blood (CB)
banks)
Lebanon

UAE

Iran

Iran

UAE

Turkey

Saudi Arabia

Egypt

Turkey

Iran

Egypt

Indonesia

Bahrain

Qatar

Malaysia

Jordan

Egypt

Egypt

Lebanon

Saudi Arabia

Kuwait

Jordan

Indonesia

Malaysia

Malaysia

Morocco

Pakistan

Pakistan

Qatar

Burkina Faso

Jordan

Lebanon

Saudi Arabia

Tunisia

Algeria

UAE

Pakistan

Saudi Arabia

Tunisia

Tunisia

Indonesia

Algeria

UAE

Kazakhstan

Oman

Palestine

Qatar

Algeria

Somalia

Nigeria

Oman

Bosnia and
Herzegovina
Jordan

Chad

Oman

Bangladesh

Albania

Sudan

Morocco

Bangladesh

Mali

Bangladesh

Iran

Brunei

Iraq

Morocco

Pakistan

Kazakhstan

Palestine

Indonesia

Kuwait

Brunei

Oman

Azerbaijan

Nigeria

Bosnia and
Herzegovina
Azerbaijan

Syria

Kazakhstan

Albania

87

Country
(Filter: Largest
R&D as % GDP)

Country
(Filter: Largest
#Publications in
Stem cells)

Country
(Filter: Largest
#Clinical Trials)

Nigeria
Uzbekistan
Kazakhstan
Kyrgyzstan
Bahrain
Tajikistan
Gambia
Kuwait
Iraq

88

Country
(Filter: Largest
#Cord blood (CB)
banks)

Table 4 – List of Top 17 Muslim Countries by HSCR Publications
# Cord
Blood
Banks
(CB)

R&D as
% GDP

#Clinical
Trials in
(Stem
Cell)

Country

Religious
Affiliation

HSCR
Policies

#Publications
(TI="Stem
Cells")

Turkey

HNF

Y

2025

6

0.96

98

Iran

SHI

Y

1206

1

0.83

77

Saudi Arabia

HNB

Y

607

3

0.58

24

Egypt

HNF

N

430

5

0.72

63

Malaysia

SHF

Y

256

4

1.44

22

Indonesia

SHF

Y

134

3

0.23

31

Pakistan

HNF

Y

125

3

0.24

15

Jordan

HNF

Y

113

2

0.71

25

Algeria

MLK

N

108

0

0.54

2

Tunisia

MLK

N

75

0

0.60

3

UAE

MLK

N

47

7

1.30

6

Qatar

HNB, MLK

N

45

3

0.82

0

Nigeria

MLK

N

38

1

0.13

0

Oman

IBD

N

37

3

0.22

1

Morocco

MLK

N

29

1

0.71

0

Bangladesh

HNF

N

27

1

#N/A

1

Kazakhstan

HNF

Y

24

1

0.12

2

89

Table 5 - Legal Positions of Non-Embryonic Stem Cell Research for the Top 17 Muslim
Countries by Affiliation
Policy Level 1

Policy Level 2

Country

Religious
Affiliation

Adult Stem Cells
(Bone Marrow,
Peripheral Blood,
Skin, Liver, etc.)

Non-IVF
(Umbilical Cord,
Placenta, Aborted
Fetuses)

Purpose

Qatar

HNB, MLK

Y

Y

TH

Saudi Arabia
Bangladesh

HNB
HNF

Y
Y

Y
Y

TH
TH

Egypt

HNF

Y

Y

TH

Jordan

HNF

Y

Y

TH

Kazakhstan

HNF

Y

Y

TH

Pakistan

HNF

Y

Y

TH

Turkey

HNF

Y

Y

TH

Oman

IBD**

Y

Y

TH

Algeria

MLK

Y

Y

TH

Morocco

MLK

Y

Y

TH

Nigeria

MLK

Y

Y

TH

Tunisia

MLK

Y

Y

TH

UAE

MLK

Y

Y

TH

Indonesia

SHF

Y

Y

TH

Malaysia

SHF

Y

Y

TH

Iran

SHI

Y

Y

TH

Religious Sects and Affiliations: Religious Sects and Affiliations: S=Sunni;
HNF=Hanafi; SHF=Shafi'i; MLK=Maliki; HNB=Hanbali; SHI=Shi’ia; IBD **=Ibadi is
not identified as one of the prominent Sunni affiliations; TH=Therapeutic; R=Research
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